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ABSTRACT 
 
Free radical-induced oxidative stress is involved in the pathogenesis of a number of 
human diseases such as diabetes mellitus, hypertension and atherosclerosis. Endothelial 
dysfunction, usually assessed as decreased endothelium-dependent vasodilation, 
precedes clinically before obvious vascular pathologies and together with oxidative 
stress are major predictors of disease progression.  Such endothelial dysfunction is 
observed early in the development of the pathology and is due, at least in part, to an 
excessive vascular formation of reactive oxygen species (ROS) in particular superoxide 
anion (O2
−
), which reduce nitric oxide (NO) bioavailability.  Epidemiological and 
clinical studies have demonstrated that a growing list of natural products, as 
components of the daily  diet or phytomedical preparations are a rich source of 
antioxidants and may improve vascular function by enhancing NO bioavailability. 
 
In our preliminary studies, the crude extract of Phoebe grandis demonstrated significant 
protection of the endothelial cells against oxidative stress induced by the pro-oxidant β-
NADH. Boldine ((S)-2,9-dihydroxy-1,10-dimethoxy-aporphine), the major compound 
in Phoebe grandis, exhibited the highest antioxidant activity, and thus,  selected for 
further studies in animal models of hypertension and diabetes mellitus.  
 
Spontaneously hypertensive rats (SHRs) and type 1 (streptozotocin-induced) diabetic 
rats were treated intraperitoneally either with vehicle or boldine (20 mg/kg) for 7 days 
while type 2 (db/db mice) diabetic mice were treated orally to investigate the chronic 
effects of boldine on vascular and endothelial functions. Repeated treatment with 
boldine significantly improved acetylcholine (ACh)-induced endothelium-dependent 
relaxation in isolated SHR aortas whilst sodium nitroprusside (SNP)-induced 
endothelium-independent relaxations remained unaltered. Furthermore, boldine 
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treatment lowered aortic O2
−
 and peroxynitrite (ONOO
−
) productions and down-
regulated the protein expression of the p47
phox
 subunit of pro-oxidant enzyme 
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase in the SHR aortas. This 
endothelial protective effect of boldine in hypertensive animals was achieved, at least in 
part, through the inhibition of NADPH-mediated O2
−
 production. Similarly, repeated 
treatment with boldine significantly improved the ACh-induced endothelium-dependent 
relaxation of the aorta in both type 1 and 2 diabetic animals but had no effect on 
endothelium-independent relaxations to SNP. In addition, boldine treatment effectively 
reduced the hyperglycaemia-induced oxidative stress level in the vascular wall of the 
diabetic rats and mice.  This protective effect of boldine was further confirmed in 
primary rat/mouse aortic endothelial cells exposed to high glucose levels. In rat aortas, 
this endothelial protective role of boldine were correlated with increased NO levels and 
reduction of vascular ROS via inhibition of the NADPH oxidase subunits, p47
phox
 and 
NOX2. In the db/db mouse type 2 diabetic model, repeated treatment with boldine 
normalized the overproduction of ROS, and this was associated with the restored level 
of eNOS phosphorylation and down-regulation of protein expression of angiotensin 
type 1 receptor (AT1R) and oxidative stress markers (bone morphogenetic protein-4 and 
nitrotyrosine). Treatment with boldine, slightly decreased blood glucose levels in the 
type 1 diabetic rat but did not have a significant effect in the type 2 diabetic mice,  
 
Taken together, it appears that boldine may exert positive effects on the endothelium via 
several mechanisms including mainly by protecting NO from degradation via inhibiting 
the excessive production and scavenging of O2
−
, and additionally by increasing NO 
bioavailability by upregulating activity of eNOS.  The present study supports a 
complimentary therapeutic role of a natural product, boldine in improving endothelial 
dysfunction associated with hypertension and diabetes mellitus by interfering with the 
oxidative stress-mediated signalling pathway. 
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ABSTRAK 
 
Stres oksidatif yang disebabkan oleh radikal bebas adalah berkaitan dengan patogenesis 
beberapa penyakit seperti diabetis, tekanan darah tinggi dan aterosklerosis. Disfungsi 
endotelial yang biasanya dinilai sebagai perencatan relaksasi ‘endothelium-dependent’ 
biasanya terjadi sebelum simptom patologi vaskular dan bersama stres oksidatif adalah 
ramalan utama untuk menilai progressi penyakit. Disfungsi endotelial selalunya berlaku 
pada peringkat awal penyakit dan disebabkan oleh pembentukan spesies oksigen reaktif 
(ROS) yang berlebihan seperti ‘superoxide anion’ (O2
−
) yang boleh mengurangkan 
kandungan nitrik oksida (NO) di dalam tisu vaskular. Kajian epidemiologi dan klinikal 
telah menunjukkan bahawa terdapat pelbagai produk semulajadi yang kaya dengan 
antioksidan dan boleh membaikpulih fungsi vaskular dengan meningkatkan kandungan 
NO di dalam tisu vaskular. 
 
Dalam peringkat awal kajian kami, ekstrak mentah Phoebe grandis menunjukkan 
aktiviti yang baik dalam melindungi sel-sel endotelial terhadap tekanan oksidatif yang 
disebabkan oleh substrat β-NADH. Boldine ((S) -2,9-dihydroxy-1,10-dimethoxy-
aporphine), kompaun utama yang ditemui dalam Phoebe grandis, telah mempamerkan 
aktiviti antioksidan yang tertinggi dan telah dipilih untuk kajian selanjutnya dalam 
model haiwan hipertensi dan diabetis. 
 
Tikus hipertensi spontan (SHRs) dan tikus diabetis jenis 1 (diinduksi dengan 
streptozotocin) telah diberikan ‘vehicle’ (20% Tween-80 atau etanol) atau ‘boldine’ (20 
mg/kg) secara intraperitoneal selama 7 hari manakala tikus diabetis jenis 2 (db/db) telah 
dirawat secara oral  untuk menyiasat kesan kronik boldine ke atas fungsi vaskular. 
Rawatan berulang dengan boldine selama 7 hari mengembalikan relaksasi endotelium 
terhadap asetilkolin (ACh) dalam aorta SHR manakala relaksasi terhadap sodium 
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nitroprusside (SNP) tidak berubah dalam semua kumpulan. Tambahan pula, rawatan 
dengan boldine telah menurunkan pengeluaran radikal bebas O2
−
 dan peroxynitrik 
(ONOO
−
) dan mengurangkan ekspresi protein subunit, p47
phox
 enzim pro-oksidan 
NADPH dalam aorta SHR. Penemuan ini mencadangkan bahawa perlindungan terhadap 
endotelium oleh boldine dalam penyakit   darah tinggi, melibatkan sekurang-kurangnya 
perencatan pengeluaran radikal bebas oleh enzim NADPH oxidase. Kajian ini juga telah 
menunjukkan bahawa rawatan berulang dengan boldine meningkatkan relaksasi 
‘endothelium-dependent’ dalam model haiwan diabetis jenis 1 dan jenis 2 tanpa 
mempunyai kesan ke atas relaksasi ‘endothelium-independent’. Di samping itu, rawatan 
berulang dengan boldine berkesan dalam mengurangkan stres oksidatif pada dinding 
vaskular yang disebabkan oleh hiperglisemia dan disahkan lagi di dalam sel-sel 
endotelium yang terdedah kepada glukosa yang tinggi. Dalam model tikus diabetis jenis 
1, manfaat boldine adalah berkaitan dengan peningkatan tahap plasma nitrik oksida dan 
pengurangan ROS vaskular melalui perencatan protein subunit NADPH oksidant 
p47
phox
. Manakala, dalam model tikus diabetis jenis 2, rawatan boldine secara berulang 
menormalkan pengeluaran radikal bebas dan ianya melibatkan rencatan ekspresi protein 
reseptor-reseptor AT1 dan penanda-penanda oksidatif (BMP4 dan nitrotyrosine). 
Dengan rawatan boldine, paras glukosa darah telah turun sedikit dalam model tikus 
diabetis jenis 1 tetapi tidak memberikan kesan yang signifikan dalam model tikus 
diabetis jenis 2. 
 
Secara ringkasnya, boldine telah menunjukkan kesan-kesan yang positif terhadap 
endotelium melalui beberapa mekanisme-mekanisme termasuk mengurangkan 
pengeluaran dan memerangkap O2
−
. Tambahan pula, boldine juga menambahkan 
kandungan NO dengan meningkatkan aktiviti eNOS. Kajian ini menunjukkan 
sumbangan positif boldine sebagai produk semulajadi dalam mengurangkan  komplikasi 
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kardiovaskular dalam penyakit darah tinggi dan diabetis adalah melalui perencatan 
mekanisme-mekanisme yang berkaitan dengan pengeluaran oksidan radikal yang 
menyebabkan stres oksidatif. 
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CHAPTER I 
INTRODUCTION 
 
1.1 Endothelial dysfunction 
The endothelium, a monolayer of cells that lines the inner wall of blood vessel is 
particularly important in the regulation of vascular homoeostasis.   Through the release 
of various local mediators, the endothelium modulates vascular tone, vascular growth, 
inflammation, cellular adhesion, and smooth muscle cell proliferation (Deanfield et al., 
2007; Nedeljkovic et al., 2003). Under normal physiological condition, the healthy 
endothelial cells maintain the balance between vasodilation and vasoconstriction. Nitric 
oxide (NO) is the most important vasodilator released by endothelium (Fenster et al., 
2003; Vanhoutte et al., 2009). Conversely, in diseased conditions, endothelium-
dependent vasoconstriction becomes more prominent and endothelial dysfunction is 
exacerbated in the presence of various vasoconstrictors, including endothelins, 
angiotension II, cyclooxygenase-derived prostanoids and superoxide anion (O2
−
) 
(Radenkovic et al., 2013). Typically, the hallmark of endothelial dysfunction is 
impaired endothelium-dependent vasodilation due to attenuated NO release and 
increases in endothelium-derived contracting factors (Cai & Harrison, 2000; Lerman & 
Burnett, 1992; Radenkovic et al., 2013). Cardiovascular risk factors commonly 
associated with endothelial dysfunction are obesity, smoking, aging, 
hypercholesterolemia, hypertension and hyperglycaemia (Brunner et al., 2005; Versari 
et al., 2009). Endothelial dysfunction is associated with various cardiovascular diseases 
including atherosclerosis, hypertension, coronary artery disease, chronic heart failure 
and diabetes mellitus (Bonetti et al., 2003; De Vriese et al., 2000; Luscher et al., 1987; 
Schafer et al., 2004; Thambyrajah et al., 2001).  
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1.2 The role of oxidative stress in hypertension and diabetes mellitus 
Nitric oxide is synthesized from L-arginine by endothelial NO synthase (eNOS), one of 
the 3 major forms of NOS presently identified. Increased degradation by reactive 
oxygen species (ROS) and reduced activation of eNOS due to deficiency of essential 
substrates or cofactors may account for the loss of NO and decreased NO bioavailability 
(Cai & Harrison, 2000; Vanhoutte et al., 2009). Several studies in cell culture, animal 
models and human vessels have shown that oxidative stress is the single most important 
mechanism implicated in endothelial dysfunction.  One of the major ROS strongly 
implicated in the pathogenesis of endothelial dysfunction is the superoxide anion (O2
−
),   
free radicals formed from the reaction of oxygen with single electron (Dong et al., 2012; 
Guzik & Harrison, 2006; Montezano & Touyz, 2012). These O2
− 
can further interact 
with other molecules to generate “secondary” ROS such as hydrogen peroxide (H2O2) 
(Valko et al., 2007). There are two important enzymatic sources of O2
−
: 1) nicotinamide 
adenine dinucleotide phosphate (NADPH) oxidase enzyme complex which catalyses the 
reduction of molecular oxygen using NADPH substrate as an electron donor.2) 
Uncoupling of eNOS, resulting in O2
−
 formation instead of NO due to deficiency of the 
substrate, L-arginine and co-factor tetrahydrobiopterin (BH4) (Nedeljkovic et al., 2003).  
Increased O2
−
 could potentially inactivate NO released by the endothelial cells and in 
turn form a highly reactive molecule, peroxynitrite (ONOO
−
) (Jay et al., 2006).  
 
Diabetes mellitus and high blood pressure are known major risk factors for 
cardiovascular diseases (CVD) and their incidences continue to increase globally. 
Recent evidence has shown that excessive oxidative stress caused by increased 
production of ROS, particularly O2
−
 and its derivatives, may account for the endothelial 
dysfunction observed in the early stages of these diseases (Johansen et al., 2005b; Li et 
al., 2004; Rizzoni, 2002; Tian et al., 2011). Reactive oxygen species may modify 
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endothelial function directly by activating several signalling cascades and redox-
sensitive transcription factors leading to modification of important roles of  many 
functional genes in vascular cells such as upregulation of adhesion molecules to 
platelets and leukocytes,  and decreasing the bioavailability of NO or increasing 
oxidation of low density lipoprotein (Griendling et al., 2000). Accumulating evidence 
suggests that NADPH oxidase is the primary source of excessive O2
−
 generator in both 
animal models of hypertension and diabetes, including angiotensin II-induced 
hypertension, genetic hypertension, renovascular hypertension and type 2 diabetic db/db 
mice (Fenster et al., 2003; Tian et al., 2011; Zalba et al., 2001). Reactive oxygen 
species are considered to play important pathological roles in cardiovascular diseases 
due to their abilities to alter the function of specific cellular proteins and enzyme as well, 
which eventually leads to alternation on the expression of pro-inflammatory molecules 
and impaired endothelium-dependent relaxation (Griendling et al., 2000). 
 
1.3 Pharmacological therapies to improve endothelial dysfunction 
Endothelial dysfunction is a systemic cardiovascular disorder and it is reversible with 
several non-pharmacological and pharmacological therapies. Regular physical exercise 
is an important non-pharmacological intervention that has been demonstrated to reduce 
oxidative stress and improve endothelial function in animal models of hypertension and 
in hypertensive patients (Higashi et al., 1995; Higashi & Yoshizumi, 2004; Yen et al., 
1995). Pharmacological agents that have been primarily known to achieve vascular 
protection includes angiotensin converting-enzyme (ACE) inhibitors, angiotension II 
receptor (ARB) blocker, calcium blockers, statins and antioxidants (Esper et al., 2000; 
Keegan et al., 1995; Koh et al., 2007; Schiffrin et al., 2002; van de Ree et al., 2001). A 
growing body of evidence has demonstrated that the major pathophysiologic processes 
of endothelial dysfunction such as loss of NO bioavailability, oxidation of LDL and the 
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vascular inflammatory response are all modulated by oxidant stress. Therefore, 
therapeutic approaches associated with antioxidants have gained considerable attention 
in recent year to ameliorate oxidant stress in vascular cells. Antioxidants such as 
vitamin C and E have been shown to effectively improve endothelial function in several 
animal models and in clinical studies (Bohm et al., 2007; Heitzer et al., 1999; Keegan et 
al., 1995; Mullan et al., 2005). Vitamin C has been reported to inhibit LDL oxidation, 
reduce monocyte adhesion to endothelial cell, decrease inactivation of NO and prevent 
homocysteine-induced impairment of vascular function (Chambers et al., 1999; Heitzer 
et al., 1996; Wu et al., 2007). Two weeks of vitamin E treatment was shown to decrease 
P-selectin in patients with hypercholesterolemia, suggesting attenuation of endothelial 
activation (Davi et al., 1998). However, the beneficial effects of antioxidants on 
cardiovascular diseases in clinical trials are limited and inconsistent. For example, long-
term studies using vitamins have not shown any positive effect on endothelium function 
(Gilligan et al., 1994; Elliott et al., 1995). Furthermore, high concentrations of the 
vitamin E have been reported to worsen endothelial function (Keaney et al.,1994) . 
Therefore, the optimal dose of an antioxidant must also be titrated and investigated in 
order to achieve an optimal beneficial effect.   
 
Apart from vitamins, a class of naturally occurring compounds called polyphenols, 
contained largely in fruits, vegetables, red wine and chocolate, have been found to 
effectively ameliorate endothelial function in peripheral large arteries (Grassi et al., 
2005; Schramm et al., 2012). It is found that polyphenols such as flavanoids, apart from 
their well-know superoxide scavenging activity, exert  their protective effect by 
inhibition of NADPH oxidase (Al-Awwadi et al., 2005). Resveratrol, a red wines 
polyphenol, has been shown to prevent platelet aggregation via inhibition of 
cyclooxygenase-1 (COX-1)  to protect endothelial cells from oxLDL-induced oxidative 
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stress by direct ROS scavenging and inhibition of NADPH oxidase (NOX) activity 
(Chow et al., 2007; Pandey & Rizvi, 2009; Szewczuk et al., 2004). The polyphenol has 
also been demonstrated to improve endothelial function by enhancing NO signalling 
pathway in vascular endothelial cells in several human and rat arteries (Rush et al., 2007; 
Zhang et al., 2009). 
 
1.4 Aims of the study 
Interventions that can ameliorate endothelial dysfunction may offer new potential 
therapeutic opportunities for treating these chronic diseases which are closely associated 
with oxidative stress. Several studies have demonstrated that administration of 
antioxidants decreased the development of endothelial dysfunction in animal models of 
hypertension and diabetes mellitus (Keegan et al., 1995; Ting et al., 1996). The first 
objective of the present study is to determine the antioxidant activities and evaluate the 
endothelial protective effect of a local Malaysian plant, Phoebe grandis on the isolated 
rat thoracic aorta. Amongst the major compounds identified from this plant, boldine 
(Figure 1.1) exhibited the most potent antioxidant activity and the greatest protection 
against endothelial dysfunction induced by β-NADPH, an enzymatic generator of O2
−
. 
Boldine has been extensively reported earlier as a potent ‘natural’ antioxidant and 
possesses several health-promoting properties like anti-inflammatory, anti-tumour 
promoting, anti-diabetic, and cyto-protective. Therefore, boldine was subsequently 
selected for further investigations in hypertensive and diabetic animals in vitro and in 
vivo.    
 
 
 
       Figure 1.1: Structure of boldine ((S)-2,9-dihydroxy-1,10-dimethoxy-aporphine) 
                                                                                                                         CHAPTER I 
6 
 
 
In addition to its antioxidant effects, boldine has been reported to promote vascular 
smooth muscle relaxations (Ivorra et al., 1993b) and however, there have been no 
reports on the antihypertensive effects of the alkaloid.  The second objective of this 
thesis is to examine the effectiveness of boldine in the treatment of endothelial 
dysfunction in spontaneously hypertensive rats (SHR), the most studied animal 
experimental model of hypertension.   
 
Similar to hypertension, increased oxidative stress due to hyperglycaemia may 
participate in endothelial dysfunctions in animal models of diabetes.  As a third 
objective, this thesis examines the therapeutic effect of acute and repeated treatment of 
boldine on high glucose-induced oxidative stress and endothelial function in the isolated 
aorta of streptozotocin (STZ)-induced diabetic rats. 
 
For the fourth objective, this thesis describes the endothelial protective effects of 
boldine treatment in db/db mice, a type 2 diabetic animal model by inhibiting Ang II-
mediated BMP4-dependent oxidative stress cascade. To further elucidate the 
mechanisms of the endothelial protective effects of boldine, this thesis describes actions 
of the aporphine alkaloid on NADPH oxidase activity, eNOS expression, free radical 
formation and nitric oxide levels in vitro and in vivo. The findings from these 
experiments are expected to address our main hypothesis whether boldine could protect 
the endothelium in chronic diseases such as hypertension and diabetes. 
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CHAPTER II 
LITERATURE REVIEW 
 
2.1 Endothelium  
The endothelium is a complex organ system which lines the inner surface of the entire 
vascular system and acts as an interface between blood and smooth muscle cells of the 
blood vessel wall (Luscher & Noll, 1995; Mas, 2009). The vascular endothelium plays a 
pivotal role in the modulation of normal vascular tone by releasing short-lived 
vasodilators and vasoconstrictors known as endothelium-derived relaxing factors 
(EDRFs) and endothelium-derived contracting factors (EDCFs) respectively (Furchgott 
& Vanhoutte, 1989; Vanhoutte & Tang, 2008). Besides controlling vascular tone, the 
endothelium also regulates haemostasis, thrombosis and inflammatory responses by 
secreting a variety of procoagulant, anticoagulant, fibrinolytic and inflammatory factors 
(Disse et al., 2009). Under normal condition, endothelial cells favourably release 
anticoagulant and EDRFs rather than other substances. Endothelium-derived relaxing 
factors such as NO, prostaglandins and endothelium-derived hyperpolarizing factors 
(EDHFs), promotes vasodilation via stimulation of intracellular guanosine 3',5'-cyclic 
monophosphate (cGMP) on smooth muscle cells (Perrella et al., 1991; Vanhoutte & 
Scott-Burden, 1994). However, in pathophysiological condition, the phenotype of 
endothelial cells is modified to facilitate vasoconstriction, inflammation, and thrombotic 
events instead of regulating normal vascular tone (Pratico, 2005).  
 
2.2 Endothelium-derived relaxing factors (EDRFs)  
Endothelium-derived relaxing factor is a relaxing substance that was serendipitously 
discovered by Furchgott and Zawadski in 1980 during experiments examining 
acetylcholine (ACh)-induced relaxation in intact rat thoracic aortas (Deedwania, 2000). 
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The release of EDRF is triggered in response to shear stress (a physical stimulation in 
vivo), neurotransmitters, autacoids, platelet products and hormones which then readily 
diffuses to adjacent vascular smooth muscle cells and causes relaxation (Vanhoutte & 
Miller, 1989). The endothelium produces at least 3 types of EDRFs which are NO, 
endothelium-derived hyperpolarizing factors (EDHFs) and prostacyclin (Vanhoutte & 
Scott-Burden, 1994). Vanhoutte et al. (1994) reported that there are differences in 
EDRFs released in the various vascular beds, e.g, large arteries mainly rely on NO and 
smaller arteries on EDHFs for relaxations.  
 
Nitric oxide is the primary EDRF molecule released in most vascular beds and it was 
universally designated as the ‘molecule of the year’ in 1992. Nitric oxide is released in 
response to endogenous vasodilators, such ACh and bradykinin, to control several 
physiological processes including thrombosis formation in platelets, vasodilatation, 
vascular remodeling and smooth muscle cell proliferation (Mitchell et al., 2008). 
Endogenous vasodilators stimulate the release of intracellular calcium (Ca
2+
) in 
endothelial cells and thereby activating NO synthesis by eNOS which catalyzes the 
oxidation of L-arginine to NO and L-citrulline (Palmer et al., 1988; Stuehr, 2004). 
Tetrahydrobiopterin (BH4) is an essential cofactor to retain the dimer formation of a 
functional eNOS (Fleming & Busse, 1999). After NO is synthesized, it diffuses rapidly 
to the vascular smooth muscle cells (VSMCs), where it activates guanylate cyclase and 
the synthesis of cyclic guanosine-3’,5-monophasphate (cGMP) from guanosine 
triphosphate (GTP) (Vallance & Chan, 2001). Cyclic GMP is an important intermediate 
second messenger which binds and activates protein kinase G (PKG) to reduce calcium 
influx and inhibit Ca
2+
-dependent muscle contraction (Koenigsberger et al., 2005) 
(Figure 2.1). 
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Figure 2.1: A general diagram illustrating the mechanism of vascular smooth muscle 
relaxation mediated by nitric oxide (NO). NO is synthesized by the endothelial nitric 
oxide synthase (eNOS) in response to endogenous vasodilators, eg, acetylcholine (ACh) 
and bradykinin, and the activation of calcium (Ca
2+
) released from the endoplasmic 
reticulum into cytoplasm. NO rapidly diffuses into vascular smooth muscle cells to 
produce cGMP and causes vasodilatation (Reproduced from Boulanger and Vanhoutte 
(1997)). 
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2.3 Endothelium-derived contracting factors (EDCFs) 
Under certain conditions, the endothelial cells also can produce several diffusible 
substances others than EDRFs to cause the vasoconstriction in VSMCs which are 
known as EDCFs, e.g, cyclooxygenase (COX)-derived prostanoids, ROS, endothelin-1 
and angiotensin II (Tang & Vanhoutte, 2010). Endothelium-dependent contraction can 
also be initiated by receptors-mediated agonists such as A23187, ACh and thrombin 
which leads to high accumulation of intracellular Ca
2+
 concentration in endothelial cells, 
a major trigger of EDCFs events (Wong & Vanhoutte, 2010). Cyclooxygenase was 
identified as the major enzyme involved in the arachidonic metabolism, leading to the 
production of endoperoxides from arachidonic acid. Endoperoxides is then further 
transformed into several prostanoids including prostacyclin (PGI2), thromboxane A2 and 
various prostaglandins and ROS is formed as a by-product (Wong & Vanhoutte, 2010). 
Endothelial dysfunction may occur due to the imbalance between EDCFs and EDRFs 
and always resulting from the overproduction of EDCFs (Wong & Vanhoutte, 2010) 
(Figure 2.2). This enhancement of the vascular tone has been demonstrated in a number 
of cardiovascular diseases and related complications (Matsumoto et al., 2007; Shi et al., 
2007; Qu et al., 2010). 
 
2.4 Reactive oxygen species (ROS) and oxidative stress 
Reactive oxygen species (ROS) is a highly bioactive molecule or chemical species 
formed by incomplete reduction of oxygen, e.g, O2
−
, OH, peroxyl radical (RO2), alkoxyl 
radical (RO). These molecules possess varying oxidizing potencies. Other molecules 
like hydrogen peroxide (H2O2), hypochlorous acid (HOCl), ozone (O3), and singlet 
oxygen (
1
O2) also possess oxidizing capability (Leonarduzzi et al., 2010). ROS has been 
reported to either directly or indirectly involve in the activation of EDCFs by triggering 
COX signalling pathway in the vascular smooth muscle cells and therefore increasing 
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vasoconstriction as well as reducing NO bioavailability (Wong & Vanhoutte, 2010). In 
the past few decades, O2
−
 has been identified as a ‘primary’ ROS which can further 
interact with other molecules to generate ‘secondary’ ROS like H2O2 or react rapidly 
with NO to form ONOO
−
 (Valko et al., 2007). 
 
Oxidative stress is defined as overproduction of pro-oxidant molecules such as reactive 
oxygen and nitrogen species, which can cause oxidative damage to bio-molecules 
(lipids, proteins, DNA, RNA) and organs (Uttara et al., 2009). An increase in oxidative 
stress is typically attributed to either an excessive over production of ROS or decreased 
endogenous antioxidant activity. Such an imbalance plays a critical contributory role in 
the pathophysiology of endothelial dysfunction. 
 
2.4.1 NADPH oxidase and pro-oxidant enzymes  
Nicotinamide adenine dinucleotide phosphate oxidase is a multi-component enzyme 
that comprises of a membrane-bound cytochrome b558 (p22
phox
 and gp91
phox
) and other 
regulatory cytosolic proteins (p47
phox
, p67
phox
, p40
phox
 and Rac) which has been found in 
membranes of vascular cells including endothelial cells, vascular smooth muscle cells 
and fibroblasts (Forstermann, 2008; Ray & Shah, 2005). Nicotinamide adenine 
dinucleotide phosphate oxidase appears to be the primary source of endothelial 
superoxide and it can potentially influence the generation of ROS by other oxidant 
enzymes like xanthine oxidase and mitochondrial enzymes. This promotes NOS 
uncoupling which leads to O2
−
 cascades and decreased bioavailability of NO (Ray & 
Shah, 2005). The other sources of ROS generating systems include arachidonic acid 
metabolizing enzymes, eg, COX, lipoxygenase, CYP epoxygenase (Li & Shah, 2004). 
An increase of oxidative stress is associated with the up-regulation of oxidant enzymes 
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which later contribute to cardiovascular complication in hypertension and diabetes 
mellitus (Forstermann, 2008). 
 
2.4.2 Angiotension II type 1 receptor (AT1R) and NADPH oxidase 
Angiotensin II (Ang II) is a bioactive product of renin-angiotensin system (RAS) and is 
known as a potent vasoconstrictor that has pro-inflammatory, mitogenic and profibrotic 
actions. There are two subtype receptors for Ang II, denoted as angiotensin II type 1 
receptor (AT1R) and angiotensin II type 2 receptor (AT2R) (Burnier & Brunner, 2000). 
It is well documented that Ang II produces vasocontriction by acting on the AT1R and 
this receptor subtype is found in both VSMCs and endothelial cells (Higuchi et al., 
2007). Upon activation by Ang II, AT1R in the plasma membrane interacts with several 
heterotrimeric G protein subunits such as Gq/11, Gi, G12 and G13 and thereby activate 
phospholipase C to form second messengers including inositol trisphosphate (IP3) and 
diacylgyecrol (DAG) (Higuchi et al., 2007). Eventually, this leads to the 
phosphorylation of the voltage-sensitive calcium channels, whereby calcium influx is 
enhanced, followed by an increase of vascular tone. 
 
There are also growing evidences indicating that AT1R not only activates the classical 
receptor-coupled calcium signalling pathway but also NADPH oxidase-dependent 
pathway (Nguyen Dinh Cat et al., 2012). Ang II is known as one of the major regulator 
of vascular NADPH oxidase to produce O2
−
 upon stimulation of AT1R, which can 
potentially increase oxidative stress cascades in the vascular endothelial cells and has 
been shown to increase NADPH-dependent O2
−
 generation in cultured human umbilical 
vein endothelial cells (HUVECs) and VSMCs (Griendling et al., 1994). Furthermore, it 
has been reported that treatment with losartan, AT1R blocker, significantly improved 
ACh-induced vasodilatations and reduced the up-regulation of NADPH oxidase and 
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oxidative stress in both hypertensive and diabetic animal models (Bayorh et al., 2005; 
Fukui et al., 1997), supporting that Ang II induced NADPH-dependent ROS generation 
via AT1R.  
 
2.4.3       ROS and vascular tone 
It is well established that ROS can regulate many physiological functions of the 
endothelium. Reactive oxygen species is known to affect vasorelaxation, in which O2
−
 
reacts with NO to generate the oxidative cascade and reduces the NO bioavailability in 
the blood vessel walls, leading to impairment of endothelium-dependent relaxations 
(Taniyama & Griendling, 2003). They also exerts a direct vasoconstrictive effect on 
VSMCs or indirectly, activates the release of EDCFs to the VSMCs through arachidonic 
acid metabolism and the latter activates endoperoxies-thromboxane A2 prostanoid (TP) 
receptors in VSMCs to evoke vasoconstriction (Taniyama & Griendling, 2003) (Figure 
2.2). 
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Figure 2.2: Schematic diagram showing the overproduction of ROS leads to 
vasoconstriction and consequently to endothelial dysfunction in vascular vessel. The 
source of ROS includes NADPH oxidase, cytochrome P450 oxidase, xanthine oxidase, 
cyclooxgenase (COX) and uncoupling of eNOS. ROS causes an increase in intracellular 
calcium level and the activation of arachidonic acid metabolism, which eventually 
results in vascular smooth muscle contraction. The production of ROS also decreases 
NO bioavailability through the rapid reaction between superoxide anion (O2
−
) and NO 
to result in peroxynitrite (ONOO
−
) formation and eNOS uncoupling (Reproduced from 
Wong & Vanhoutte, 2010 and Vanhoutte, 2002). 
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2.4.4 Bone morphogenic protein-4 (BMP4) and oxidative stress 
Bone morphogenetic protein-4 (BMP4) is multi-functional growth factors which 
belongs to the transforming growth factor-β superfamily and is found in calcified 
atherosclerotic plaques (Dhore et al., 2001). Studies have showed that BMP4 plays a 
role in vascular inflammation (Miriyala et al., 2006; Sorescu et al., 2003). Previous 
studies have demonstrated that BMP4 is up-regulated following exposure to disturbed 
flow and oxidative condition in cultured endothelial cells triggering NADPH-dependent 
ROS generation and inflammatory responses (Sorescu et al., 2004). Recently, a study 
by Bostrom et al., (2011) have also showed that high glucose promotes BMP4 
expression in cultured human aortic endothelial cells that is associated with the vascular 
calcification. Moreover, BMP4 has been increasingly reported to impair endothelial 
function in mouse aortas either by increased ROS formation through NADPH oxidase 
or cyclooxygenase-2 (Miriyala et al., 2006), suggesting the possibility that BMP4 may 
play a pivotal role in vascular disease such as hypertension, diabetes and atherosclerosis. 
However, BMP4 only exerts its pro-oxidant, pro-hypertensive and pro-inflammatory 
effect in the systemic arteries such as aorta, carotid or coronary arteries, whereas 
pulmonary arterial endothelial cells are resistant to the adverse effect induced by BMP4 
(Csiszar et al., 2008). 
 
2.2 Cellular antioxidant system 
The degree of oxidative stress is dependent on the fine balances between the generation 
of ROS and the antioxidant systems. Antioxidant is a reducing agent that plays a crucial 
role in protecting the cells against the excessive ROS formation by reacting with the 
ROS and therefore minimizing their action (Gomes et al., 2012; Nordberg & Arner, 
2001). Generally, cellular antioxidant system can be divided into two groups, enzymatic 
and non-enzymatic. The important enzymatic antioxidants include (1) catalase (CAT), 
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responsible to degrade H2O2 into H2O (2) glutathione peroxidase (GPx), protects 
membrane lipids, proteins and nucleic acids from oxidation by reducing H2O2 into H2O 
and (3) superoxide dismutase (SOD), converts O2
−
 into O2 and H2O2. These enzymatic 
antioxidants are usually located in different cellular compartments such as cytosol and 
mitochondria (Gomes et al., 2012). The non-enzymatic antioxidant compound includes 
vitamin C, vitamin E, lipoic acid, ubiquinones, caratenoids and polyphenol derived from 
dietary sources (Uttara et al., 2009). 
 
2.6 Endothelial dysfunction 
Hypertension and diabetes mellitus affects the health of millions worldwide and are 
major risk factors for cardiovascular disease, the number one killer globally. There are 
increasing evidences demonstrating excessive oxidative stress may account for the 
endothelial dysfunction in the early stages of these diseases. Among the major cause of 
the endothelial dysfunction is the overproduction of ROS such as O2
−
. The O2
−
 may 
either bind or inactivate the NO released from the endothelium or combine with the later 
to form another toxic radical, ONOO
−
 (Li & Shah, 2004). In addition to their important 
physiological roles in the body, ROS are implicated in the pathogenesis of many acute 
and chronic diseases. In the cardiovascular system, these oxygen radicals may decrease 
the bioavailability of EDRFs such as NO or alter the function of cellular proteins, 
nucleic acids and lipids in cardiac membranes, leading to endothelial dysfunctions and 
cell death (Li & Shah, 2004). 
 
2.6.1 Endothelial dysfunction in hypertension 
Hypertension defined as elevated blood pressure, can result when total peripheral 
vascular resistance is increased (Carretero & Oparil, 2000; Virdis et al., 2011). The risk 
factors that contribute to the increase of blood pressure include obesity, insulin 
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resistance, high alcohol intake, high salt intake (in salt-sensitive patients), aging and 
stress (Virdis et al., 2011). There are two form of hypertension: primary hypertension 
and secondary hypertension. Primary or essential hypertension is seen in almost 90% of 
the patient presenting with hypertension with an unknown cause. It is classified as 
secondary hypertension if the increase in blood pressure is secondary to renal disease, 
endocrine disorders, or other identifiable causes (Acelajado & Calhoun, 2010). Impaired 
endothelium-dependent relaxations have been well documented in several 
cardiovascular diseases such as hypertension and atherosclerosis (Ajay et al., 2006a; 
Benndorf et al., 2007; Jang et al., 2000b) Similarly, endothelial dysfunctions are also a 
common feature in various animal models of hypertension including spontaneously 
hypertensive rats, salt-induced hypertension and renovascular hypertension (Benndorf et 
al., 2007; Heitzer et al., 1999; Hermann et al., 2003; Lockette et al., 1986). 
 
De Champlain et al (2004) demonstrated a greater sensitivity of the vascular tissue of 
SHRs to oxidative stress and it is attributed to the excess production of vascular ROS 
such as O2
−
. The exaggeration of ROS production in vascular tissues not only decreased 
the NO bioavailability but also reduced the antioxidant capacity of the smooth muscle 
cells. Of note, almost all experimental models of hypertension have been associated 
with the excessive oxidative stress production. For example, Ang II- and diet-induced 
animal models, as well as genetically modified hypertensive rat models have been 
reported to exhibit increased vascular oxidative stress via the activation of NADPH 
oxidase (Lee & Griendling, 2008; Touyz & Briones, 2011). Furthermore, an up-
regulation of NADPH subunit (p22
phox
 or p47
phox
) have been demonstrated in aortas of 
hypertensive rat models whilst NADPH knockout animal attenuated the development of 
hypertension, suggesting that NADPH oxidase is probably one of the major enzymatic 
sources of O2
−
 (Dikalova et al., 2005; Fukui et al., 1997; Zalba et al., 2000). 
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Hypertensive patients are also reported to have reduced antioxidant capacity with lower 
expression of SOD, catalase and GSH peroxidase in the whole blood and peripheral 
mononuclear cells from hypertensive patients (Redon et al., 2003). Elevated blood 
pressure have been also reported in animal model in which GSH synthesis was inhibited 
and extracellular SOD gene deleted (Welch et al., 2006). 
 
Excess O2
−
 leads to greater vasoconstriction by the altering in the cellular signal 
transduction system characterized by an enhanced production of IP3 and a reduced 
cGMP (De Champlain et al., 2004). It is worth noting that apart from reduced 
endothelium-dependent relaxations, endothelium-dependent contraction (EDC) also 
significantly contributes to the development of endothelial dysfunctions in hypertension 
(Vanhoutte & Tang, 2008). 
 
2.6.2 Endothelial dysfunction in diabetes mellitus 
Diabetes mellitus presents a growing health and socioeconomic problem especially in 
developing countries like Malaysia. The hyperglycaemia in diabetes may result from 
poor glucose utilization or defective insulin secretion, insulin resistance or both (Wei et 
al., 2003). There are two types of diabetes mellitus: type 1 and type 2. Type 1 diabetes 
is caused by pancreatic β-islet cell failure with resulting insulin deficiency, 
encompasses 5-10 % of diabetes diagnosed. While type 2 diabetes, accounting for 
almost 90 % of diabetics are characterized by insulin resistance (Jay et al., 2006). 
Reactive oxygen species generated by hyperglycaemia are implicated in the 
microvascular and macrovascular complications in diabetic patients. These 
microvascular complications include nephropathy and retinopathy, while macrovascular 
complications include atherosclerotic cardiovascular diseases (Johansen et al., 2005b).  
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Endothelial dysfunction has been demonstrated in both type 1 and type 2 diabetes, 
which is associated with decreased level of EDRFs following increased destruction by 
ROS (De Vriese et al., 2000). Glucose oxidation is believed to be a main source of ROS 
generation in diabetes followed by glycation and protein kinase C (PKC) activation 
(Maritim et al., 2003; Wiernsperger, 2003). Similar to hypertension, excessive oxidative 
stress has been associated with the increased production of O2
−
 via NADPH oxidase and 
accounts for the endothelial dysfunction in the early stage of the disease (Heitzer et al., 
2001). Impaired endothelium-dependent vasodilatations had been observed in several 
animal models of type 1 and type 2 diabetes including streptozotocin (STZ)-induced 
diabetes, db/db mice, Otsuka Long-Evans Tokishima Fatty (OLETF) rats and Goto-
Kakizaki (GK) rats (Gupte et al., 2010; Kim et al., 2002; Tian et al., 2011; Woodman & 
Malakul, 2009). 
 
There are increasing evidences showing that the increased production of ROS interferes 
with NO-cGMP signaling (De Vriese et al., 2000, Van den Oever et al., 2010). In both 
diabetic patients and animal models, elevated generation of oxidative stress has been 
linked to the up-regulation or activation of oxidant enzymes such as NADPH oxidase 
and impaired of antioxidant enzymes system such as SOD, catalase and glutathione 
peroxidase, leading to excess ROS production (Guzik et al., 2006; Guzik et al., 2004; 
Maritim et al., 2003; Olukman et al., 2010). Nicotinamide adenine dinucleotide 
phosphate-induced O2
−
 reacts rapidly with NO to form the toxic ONOO
−
, which in turn 
uncouples eNOS by oxidizing the essential NOS redox-sensitive co-factor BH4 and 
cause eNOS to initiate O2
−
 cascades (Woodman & Malakul, 2009; Zou et al., 2004). In 
consequence, reduced NO bioavailability leads to impaired endothelium-dependent 
relaxations. It has been recently demonstrated that O2
−
 scavengers like tempol and SOD 
reversed the endothelial dysfunction in STZ-induced diabetic and db/db mice (Moien-
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Afshari et al., 2008; Serizawa et al., 2011). In addition, several antioxidants such as 
vitamin C and vitamin E has also been reported to prevent the development of 
endothelial dysfunction in diabetic patients and STZ-induced diabetic animals, 
suggesting the protective effect of antioxidant in reversing endothelial dysfunction in 
diabetic patients and animal models (Keegan et al., 1995; Ting et al., 1996). 
 
2.6.3 Therapeutic strategies for treating endothelial dysfunction  
Impaired endothelium-dependent relaxation with reduced NO bioavailability and 
increased oxidative stress are the most common features of the diseases associated with 
the cardiovascular events. Numerous studies have evaluated both non-pharmacological 
and pharmacological interventions to improve and reverse endothelial function in 
cardiovascular diseases (Table 2.1). Regular exercise is an example of non-
pharmacological interventions that has been shown to improve endothelial function by 
up-regulating eNOS protein expression and phosphorylation (Hambrecht et al., 2003). 
Others non-pharmacological interventions including lifestyle and dietary modifications 
have also been shown to decrease insulin resistance, increase adiponectin levels and 
improve endothelial function in clinical studies (Kim et al., 2006; Milan et al., 2002; 
Yang et al., 2001). For example, Sasaki et al. (2002) reported that 2 weeks of caloric 
restriction in dietary significantly resulted in weight loss and improvement of 
endothelial-dependent vasodilation through an increased release of NO in obese 
hypertensive patients. 
 
The pharmacological strategies, which include the use of ACE inhibitors, statins, ARB 
blockers and antioxidants, have been known to improve endothelial function, ameliorate 
oxidative stress and limit cardiovascular risk in diseases. The effects of pharmacological 
treatment on endothelial function and cardiovascular risk are summarized in Table 2.1.
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Table 2.1: Non-pharmacological and pharmacological therapies for treating endothelial dysfunction from the reviewed clinical studies 
Treatment  Patient condition Result in endothelial function References 
Non-pharmacologic therapy 
Regular aerobic exercise 
 
Young, old sedentary 
 
↑ EDV 
 
(DeSouza et al., 2000) 
Weight loss Premenopausal obese women ↑ EDV 
↓ Cytokine and adhesion 
concentrations 
(Ziccardi et al., 2002) 
Caloric restriction and weight loss Obese hypertensive patients ↑ EDV 
↑ NO 
(Sasaki et al., 2002) 
Pharmacologic therapy 
Statins (Atorvastatin or 
cerivastatin)  
 
Hypercholesterolemic patients 
 
↑ EDV 
 
(John et al., 2005) 
Flavanoids Coronary artery disease, 
hypertensive patients 
↑ EDV 
↓ Blood pressure 
(d'El-Rei et al., 2013; Duffy 
et al., 2001) 
Vitamin C Hypercholesterolemic patients 
and diabetes mellitus 
↑ EDV (Regensteiner et al., 2003; 
Ting et al., 1997) 
Vitamin E Diabetes mellitus ↑ EDV (Economides et al., 2005; 
Regensteiner et al., 2003) 
ARB blocker (Telmisartan) Hypertension and impaired 
glucose tolerance 
↑ EDV 
↓ Insulin resistance  
↑Glucose tolerance  
(Perl et al., 2010) 
β-receptor blocker (Nebivolol) Cardiac syndrome X ↓High-sensitivity C-reactive protein  
↓von Willebrand factor  
↓ Fibrinogen  
(Kayaalti et al., 2010) 
ACE blocker (Zofenopril) Mild hypertensive patients ↑ EDV 
↓ Blood pressure 
↑ Antioxidant activty 
(Pasini et al., 2007) 
Abbreviations: EDV, endothelium-dependent vasodilation
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2.7 Boldine 
In recent years, interests in the use of ‘natural’ antioxidants in the treatment of oxidative 
stress-related diseases including hypertension and diabetics have grown exponentially. 
Boldine ((S)-2,9-dihydroxy-1,10-dimethoxy-aporphine) is a aporphine alkaloid found 
abundantly in the leaves and bark of Chilean boldo tree (Peumus boldus Molina), a 
widely distributed tree native to central region of Chile (O'Brien et al., 2006). Over a 
past decade, boldine was also found as one of the major alkaloid in the bark of a local 
tree in northern part of Peninsular Malaysia (Mukhtar et al., 1997). Boldine-containing 
herbal teas are gaining popularity in South America and its usage has been extended to 
some European countries for further pharmaceutical processing into boldine-containing 
concentrates. Boldine has been extensively reported earlier as a potent ‘natural’ 
antioxidant and possesses several health-promoting properties like anti-inflammatory, 
anti-tumour promoting, anti-diabetic, and cyto-protective. These activities of boldine 
have been attributed to its ability to scavenge reactive free radicals (O'Brien et al., 
2006). 
 
Boldine has also been reported to protect the red blood cells against free radical-induced 
haemolytic damage, even in micro molar concentrations (Jimenez et al., 2000); inhibit 
spontaneous autoxidation of brain membrane lipids and prevent lipid peroxidation in 
human liver microsomal (Kringstein & Cederbaum, 1995); protect lysozyme 
inactivation against AAPH-derived peroxyl radicals damage (Cassels et al., 1995; 
Speisky et al., 1991) and to scavenge hydroxyl radicals (Jang et al., 2000a). In addition, 
boldo extracts (Peumus boldus) containing boldine was found to effectively inhibit lipid 
peroxidation in erythrocytes (Schmeda-Hirschmann et al., 2003). Boldine has been 
shown in several studies to have anti-inflammatory properties via its ability in 
interfering with the free radical generation (Backhouse et al., 1994; Milian et al., 2004). 
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In low density lipoprotein receptor knockout (LDLR
-/-
)mice, treatment with boldine for 
12 weeks decreased atherogenic lesion formation and inhibited oxidation of low density 
lipoprotein (LDL) without altering plasma cholesterol, triglycerides, LDL and HDL 
levels (Santanam et al., 2004). In the STZ-induced diabetic model, treatment with 
boldine for 8 weeks decreased malondialdehyde (MDA) and carbonyls in liver, kidney 
and pancreas mitochondria and normalize the elevated Mn-SOD and GSH-peroxidase 
activity in pancreas mitochondrial (Jang et al., 2000). It has also been reported to exert a 
concentration-dependent muscle relaxing effects in intestinal and uterus by directly 
interfering with the nicotinic ACh receptor (Ivorra et al., 1993b). Furthermore, it has 
been shown to block the α1-adrenoceptor in rat (Ivorra et al., 1993a) and guinea pig 
aorta (Chulia et al., 1996). 
 
In addition, boldine has been indicated to have low toxicity. Boldine given in drinking 
water (100 mg/kg) prevented oxidative mitochondrial damage and possess anti-diabetic 
effect (Jang et al., 2000a). Boldine (20 mg/kg, i.p) also exhibited both free radical 
scavenging and antinociceptive activities in mice (Zhao et al., 2006). Relatively high 
doses are required to cause side effects, toxicity or lethality in several mammalian 
species, for example, doses of 500 and 1000 mg/kg were required to cause death of 
mice and guinea pigs respectively (Kreitmair, 1952; O'Brien et al., 2006). 
 
Epidemiologic studies have demonstrated that dietary and supplemental intake of 
antioxidants has reduced the coronary artery diseases or cardiovascular events. 
Therefore, the present research explores the therapeutic potential of ‘natural’ 
antioxidant boldine, an aporphine alkaloid on endothelial function in animal models of 
hypertension and diabetes mellitus. This research works should address the following 
aspects: 
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1) The endothelial protective effect of a local Malaysian plant, Phoebe grandis on the 
isolated rat thoracic aortas exposed to β-NADH and pyrogallol-induced O2
−
 in vitro.  
2) A novel role of boldine as a potent antioxidant in treating endothelial dysfunction in 
hypertensive and diabetic animals.  
3) To identify several oxidative stress markers, in particularly a major source of O2
− 
generator NADPH oxidase, in hypertensive and diabetic aortas.  
4) To clarify the protective role of boldine on endothelial function and its underlying 
mechanism by evaluating vascular reactivity, NO levels, ROS production, activity of 
eNOS, NADPH oxidase-mediated and Ang II-mediated O2
−
 production.   
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CHAPTER III 
REACTIVE OXYGEN SPECIES-INDUCED IMPAIRMENT OF 
ENDOTHELIUM-DEPENDENT RELAXATIONS IN RAT AORTIC RINGS: 
PROTECTION BY METHANOLIC EXTRACTS OF PHOEBE GRANDIS 
 
3.1 Abstract 
Generation of reactive oxygen species (ROS) plays a pivotal role in the development of 
cardiovascular diseases. The present study describes the effects of the methanolic 
extract of Phoebe grandis (MPG) stem bark on ROS-induced endothelial dysfunction in 
vitro. Endothelium-dependent (acetylcholine, ACh) and -independent relaxation 
(sodium nitroprusside, SNP) was investigated on isolated aorta of Sprague Dawley (SD) 
rat in the presence of the β-NADH (enzymatic superoxide inducer) and MPG extract. 
Superoxide anion (O2
−
) production in aortic vessels was measured by lucigenin 
chemiluminesence. Thirty minutes incubation of the rat aorta in vitro with β-NADH 
increased superoxide radical production and significantly inhibited ACh-induced 
relaxation. Pre-treatment with MPG (0.5, 5 and 50 μg/ml) restored the ACh-induced 
relaxation (Rmax: 92.29 ± 2.93%, 91.02 ± 4.54% and 88.31 ± 2.36%, respectively) in the 
presence of β-NADH. Methanolic extract of Phoebe grandis was ineffective in 
reversing the impaired ACh-induced relaxation caused by pyrogallol, a non-enzymatic 
superoxide generator. Superoxide dismutase (a superoxide scavenger), however, 
reversed the impaired ACh relaxation induced by both β-NADH and pyrogallol. 
Methanolic extract of Phoebe grandis also markedly inhibited the β-NADH induced 
generation of the superoxide radicals. Furthermore, MPG scavenged peroxyl radicals 
generated by tBuOOH (100 µM).These results indicate that MPG may improve the 
endothelium dependent relaxation to ACh through its scavenging activity as well as by 
inhibiting the NADH/NADPH oxidase induced generation of O2
−
. 
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3.2 Introduction 
The vascular endothelium plays a pivotal role in regulating normal vascular tone and 
maintaining uninterrupted blood flow in the vessels (Balakumar et al., 2009). Under 
normal conditions, the endothelium regulates vascular homeostasis by releasing a 
variety of factors that act locally in the blood vessel wall and lumen, such as nitric oxide 
(NO), prostacyclin and endothelin. Nitric oxide released from the endothelium in 
response to various vasoactive factors such as ACh plays a key role in the maintenance 
of smooth muscle relaxation. Vascular endothelial dysfunction may be defined as 
impairment in endothelium dependent vasodilatation and alteration in the normal 
properties of endothelium (Stehouwer, 2004). The vascular dysfunction results in 
reduced activation of endothelial nitric oxide synthase (eNOS), and reduced generation 
and bioavailability of NO (Calles-Escandon & Cipolla, 2001). Among the factors 
contributing to the endothelial dysfunction is the overproduction of reactive oxygen 
species (ROS) such as superoxide anion (O2
−
) which binds and inactivates NO released 
from the endothelium (Berry et al., 2001). Phoebe grandis (Nees) Merr is a local 
Malaysian timber tree of some 20 m in height with yellowish brown flowers (Mukhtar 
et al., 1997). Mukhtar et al. (2009) recently demonstrated that the stem bark of Phoebe 
grandis contains several known isoquinoline alkaloids: (-)-8,9-dihydrolinearisine, 
boldine, norboldine, lauformine, scortechine A and scortechine B and a novel 
oxoproaporphine; (-)-grandine A. Two of the aporphine alkaloids, boldine and 
norboldine have been demonstrated to have several pharmacological actions including 
anti-inflammatory, anti-cancer, anti-diabetic and potent antioxidant activities (O'Brien 
et al., 2006; Zhao et al., 2006). Plants rich in antioxidants are much sought out for their 
therapeutic potential, particularly in the prevention of cardiovascular diseases such as 
atherosclerosis, heart failure and hypertension. Several studies with these pytochemicals, 
including green tea, showed improved endothelial function by inhibiting O2
−
 production 
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or scavenging the O2
−
 (Ajay et al., 2006b; Nakagawa & Yokozawa, 2002; Romero et al., 
2009; Vera et al., 2007). In the present study, we investigated the endothelial protective 
effect of the methanolic extract of Phoebe grandis (MPG) on the NADH/NADPH 
oxidase induced oxidative stress in the isolated rat thoracic aorta. 
 
3.3 Materials and methods 
3.3.1 Chemicals and drugs 
Dichlorofluorecesin, tert-butylhydroperoxide (tBuOOH), ACh, SNP, β-NADH, SOD, 
pyrogallol, DECTA and DPI were purchased from Sigma Aldrich Chemicals. HepG2 
was purchased from ATCC (American Type Culture Collection). Chemicals used for 
Krebs solution preparation were purchased from BDH. 
 
3.3.2 Preparation of methanolic extract of Phoebe grandis (MPG) 
Bark of Phoebe grandis (Nees) Merr. (Lauraceae) were collected at Sik, Kedah (1994) 
by G. Perromat (Institut de Chimie des Substances Naturelles, CNRS, Gif sur Yvette, 
France). Identification was made by Dr K. M. Kochummen (Forest Research Institute of 
Malaysia, Kepong, Malaysia). Voucher specimens (KL 4318) are deposited at the 
Laboratoire de Phanerogamie, Museum National d’Historie Naturelle in Paris, the 
Herbarium of Department of Chemistry, University of Malaya, Kuala Lumpur, 
Malaysia and the Herbarium of the Forest Research Institute, Kepong, Malaysia. A total 
of 11.5 g of crude extract was obtained from the bark (1 kg). Crude product underwent 
column chromatography on silica gel with CH2Cl2 containing increasing amount of 
methanol and subsequent purification by preparative thin layer chromatography.  
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3.3.3 Cell based intracellular anti-oxidant assay of MPG extract 
The intracellular antioxidant activity of the MPG extract was evaluated against the 
formation of intracellular ROS in HepG2 cells after treatment with t-BuOOH (tert butyl 
hydroperoxide), a compound used to induce oxidative stress. The cells were seeded in 
96 wells plate at 3 × 10
4
 cells/well (Black plate with transparent bottom) and incubated 
for 24 h at 37 °C in 5% CO2. The next day, various concentrations of MPG extract was 
added into the wells and incubated again for another 1 h. The MPG extracts were 
dissolved in DMSO and the final concentration of DMSO (0.2%) used were not toxic to 
the cells or affect the assay. Next, cells were washed with phosphate buffered saline 
(PBS) and followed with the incubation with 10 μM dichlorofluorecesin (DCF) for 60 
min. Then, cells were washed and incubated with 100 μM tBuOOH for 60 min to 
induce oxidative stress. The plate was read at 485/535 nm. Results were expressed as a 
percentage inhibition of control. 
 
3.3.4 Preparation of aortic rings 
Twelve weeks old male Sprague-Dawley (SD) rats were obtained from the University of 
Malaya animal house and housed in well ventilated room at ambient temperature. They 
were provided with normal rat chow and tap water ad libitum. All experiments were 
reviewed and approved by the University of Malaya Animal Care and Ethics Committee 
(Ethics number: FAR/27/01/2010/0112/LYS). The rats were killed by cervical 
dislocation and aorta from the thoracic region was excised and cleared from any 
adherent fat and connective tissue with extra care to avoid any damage to the 
endothelium. The thoracic aorta was cut into small rings (3-5 mm in width) and 
suspended in a 5 ml organ bath containing Krebs physiological salt solution (pH 7.4) of 
the following composition (mM): NaCl 118, KCl 4.7, CaCl2·2H2O 2.5, KH2PO4 1.2, 
MgSO4.7H2O 1.2, glucose 11.7, NaHCO3 25.0, and EDTA 0.026. The tissue-bath 
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solution was aerated continuously with 95% oxygen and 5% carbon dioxide at 37 °C. 
Isometric tension (g) was measured using a force displacement transducer connected to 
a Mac Lab recording system (ADI Instruments, Australia). The aortic rings were 
allowed to equilibrate for 20 min under resting tension of 1 g before any initiation of 
experimental protocols. Each experiment was conducted with a minimum of 5-8 
numbers of rats. 
 
3.3.5 Pharmacological studies 
After equilibration, the rings were repeatedly stimulated with KCl solution (high K
+
, 80 
mM) for 4 min at 10 min intervals until two consecutive equal contractions were 
reached. Following washout of high K
+
 responses, vascular relaxation study was 
performed by doing cumulative concentration-response curves to the endothelium-
dependent and -independent relaxant agonists, acetylcholine (ACh, 0.1 nM to 10 µM) 
and sodium nitroprusside (SNP, 0.01 nM to 1 µM), respectively. To test the relaxation 
responses to ACh and SNP, the aortic rings were pre-contracted with phenylepherine, 
Phe (1 μM). To investigate the involvement of O2
−
 on vascular relaxation, the aortic 
rings were pre-incubated for 30 min in the presence of β-NADH (300 μM, induces O2
−
 
through NADH/NADPH oxidase) prior to conducting concentration curve to ACh and 
SNP. To investigate the scavenging ability of MPG extract, various concentration of the 
extract (0.5, 5 or 50 μg/ml) was incubated with β-NADH for 30 min prior to ACh and 
SNP concentration response study. In other experiments, pyrogallol (10 μM) was 
incubated with the aorta to generate the O2
−
 independent of NADH/NADPH oxidase. 
Superoxide dismutase (SOD, 50 U/ml), a superoxide scavenger was used as a positive 
control. Pre-incubation with β-NADH, SOD and pyrogallol did not affect the resting 
tension of the aortic tissue. Indomethacin (10 μM) was added in all experiments to 
exclude the influence of prostaglandin. 
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3.3.6 Measurement of superoxide anion 
Lucigenin-enhanced chemiluminescence assay is performed as described previously by 
Chan et al. (2003) with some modification. The aortic rings were pre-incubated at 37 °C 
in Krebs-Hepes buffer containing diethylythiocarbamic acid (DETCA, 10 mM) and β-
NADH (0.3 mM) and either vehicle (20% Tween 80), MPG extract (0.005 μg/ml- 50 
μg/ml) or diphenylene iodonium (DPI, NAD(P)H oxidase inhibitor) for 45 min. The 
rings were then transferred to a 96-well plate in luminometer (Plate CHAMELEONTM, 
Hidex, Finland). The background photon was measured previously for 20 min in the 
presence of 5 μM of lucigenin and Krebs-Hepes buffer. The output of 
chemiluminescence was then measured for 20 min. All of the samples were dried in a 
65 °C oven for 48 h. The results are expressed as counts per milligram dry weight tissue 
(i.e., count/ mg). 
 
3.3.7 Calculations and statistical analysis 
The concentrations indicated in the text or in the figures represent the final tissue-bath 
concentrations of respective drugs. The responses were recorded as mean ± standard 
error of the mean (SEM) and ‘n’ indicates number of rats used for each set of data. 
Statistical evaluation of the data for pharmacological studies and chemiluminescense 
assay was performed by unpaired Student's t-test when comparing means of two groups 
and one-way analysis of variance (ANOVA) and Dunnett post hoc test for more than 
two group comparisons. A value of P < 0.05 was considered statistically significant. 
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3.4 Results 
3.4.1 Effect of MPG extract on tBuOOH-induced intracellular oxidative stress 
In the present study, the MPG extract protected the cells against the oxidative stress 
effect of ROS generated by tBuOOH (100 µM). At the highest concentration, MPG (3 
mg/ml) inhibited almost completely the oxidative stress induced by tBuOOH (Figure 
3.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: Effect of various concentrations Phoebe grandis (stem bark) methanolic 
extract on oxidative stress induced by tBuOOH (100 µM). Quercetin (0.3 mM) was 
used as positive control. 
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3.4.2 Effect of MPG extract on vascular relaxations 
Concentration dependent vasorelaxation was observed with both ACh and SNP. 
Maximal relaxation induced by ACh at 10 µM and SNP at 0.1 µM was 93.36 ± 3.82% 
and 105.09 ± 3.87%, respectively (Figure 3.2A and 3.2B). 
 
Presence of β-NADH attenuated ACh induced relaxation (Rmax: 66.64 ± 1.25%) and 
reduced the responses to SNP (1-100 nM) without marked effects on maximal 
relaxation (Rmax: 98.67 ± 3.94%) (Figure 3.2). Presence of β-NADH slightly decreased 
the sensitivity of ACh and SNP (Table 3.1).  
 
Pre-incubation with MPG extract alone or the vehicle (0.1% DMSO), did not affect the 
vascular responses to ACh (Appendix A). MPG extract also did not affect the resting 
tension of the aortic rings or the KCl-induced contraction. In the presence of β-NADH, 
pre-incubation with different concentrations of MPG extracts (0.5, 5 and 50 μg/ml) 
significantly improved the ACh induced relaxations (Rmax: 92.29 ± 2.93%, 91.02 ± 4.54% 
and 88.31 ± 2.36%, respectively) (Figure 3.2A). In the presence of β-NADH, pre-
incubation of 50, 5 or 0.5 μg/mL MPG extract did not significantly affect the SNP 
maximal relaxation compared to the control (Figure 3.2B). The different concentrations 
of the extract only slightly reversed the decreased sensitivity of ACh and SNP which 
was seen in the presence of β-NADH (Table 3.1). 
 
In the presence of SOD and β-NADH, ACh-induced relaxation was significantly 
improved compared with the group with β-NADH alone. The improvement in ACh 
relaxation was similar to those observed with 0.5 μg/ml extract (Figure 3.3A). ACh- 
induced relaxation was impaired in the presence of 10 μM pyrogallol with maximal 
relaxation at 1 µM ACh 30.33% compared to control 93.36%. The pEC50 of ACh 
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induced relaxation in the presence of pyrogallol was not significantly altered compared 
to the control (-6.30 ± 0.68 vs -7.18 ± 0.13, respectively). Pre-incubation of 0.5 μg/ml 
extract did not alter the impaired relaxation caused with pyrogallol (pEC50, -6.76 ± 
0.23). However, pre-incubation of the aorta with SOD, markedly reduced the inhibitory 
effects of pyrogallol on the ACh-induced relaxation of the aorta (pEC50, -6.67 ± 0.34) 
(Figure 3.4). 
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Figure 3.2: Effect of 0.5 μg/ml, 5 μg/ml and 50 μg/ml Phoebe grandis (stem bark) 
methanolic extract on (A) ACh- and (B) SNP-induced relaxation in rat aortic rings 
induced oxidative stress by β-NADH. Results are mean ± SEM (n = 5-6). * P < 0.05 
compared to control, # P < 0.05 compared to β-NADH. 
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Figure 3.3: Effect of SOD, a superoxide scavenger and 0.5 μg/ml Phoebe grandis (stem 
bark) methanolic extract in the presence of β-NADH on (A) ACh and (B) SNP- induced 
relaxation in rat aortic rings. Results are mean ± SEM (n = 5-6). * P < 0.05 compared to 
control, # P < 0.05 compared to β-NADH. 
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Figure 3.4: Effect of SOD, a superoxide scavenger and 0.5 μg/ml Phoebe grandis (stem 
bark) methanolic extract in the presence of pyrogallol (non-enzymatic superoxide 
inducer) on ACh-induced relaxation in rat aortic rings. Results are mean ± SEM (n= 5-
6). * P < 0.05 compared to control, # P < 0.05 compared to pyrogallol. 
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Table 3.1: Agonist sensitivity (pEC50) and % maximum response (Rmax) value for ACh- 
and SNP-induced relaxation in rat aortic rings pre-treated with various concentrations of 
MPG extract or SOD in the presence of β-NADH or pyrogallol. Results are mean ± 
SEM (n = 4-6). * P < 0.05 compared to control; # P < 0.05 compared to β-NADH 
 
 ACh SNP 
 pEC50 
(log M) 
Rmax (%) pEC50 
(log M) 
Rmax (%) 
Control 7.29 ± 0.13 93.36 ± 3.83 8.01 ± 0.11 105.09 ± 3.87 
0.5 μg/ml extract 7.49 ± 0.19 92.96 ± 2.93 # 8.36 ± 0.28 95.33 ± 1.83 
5 μg/ml extract 7.42 ± 0.16 91.02 ± 4.54 # 8.40 ± 0.19 93.63 ± 3.19 
50 μg/ml extract 6.94 ± 0.34 88.31 ± 2.36 # 8.23 ± 0.11 107.02 ± 4.69 
β-NADH  6.99 ± 0.16 66.64 ± 1.25 * 7.52 ± 0.28 * 98.67 ± 3.94 
β-NADH + 0.5 μg/ml extract 7.34 ± 0.27 91.30 ± 2.49 # 8.53 ± 0.13 105.21 ± 3.70 
β-NADH + SOD 7.48 ± 0.18 84.00 ± 6.72 # 8.35 ± 0.13 96.33 ± 4.02 
Pyrogallol  6.30 ± 0.68 30.33 ± 3.30 * N/A N/A 
Pyrogallol + 0.5 μg/ml extract 6.76 ± 0.23 35.22 ±1.63 * N/A N/A  
Pyrogallol + SOD 6.67 ± 0.34 60.66 ± 5.30 # N/A N/A 
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3.4.3 Effect of MPG extract on β-NADH-mediated vascular superoxide production 
Measurement of O2
−
 by lucigenin-enhanced chemiluminesence assay demonstrated that 
MPG dose-dependently reduced O2
− production induced by β-NADH (Figure 3.5). 
Without the presence of β-NADH, the vasuclar O2
−
 production from isolated rat aortic 
ring was 100 ± 50 counts/mg. In the presence of β-NADH, the superoxide radical 
production increased to 350 ± 50 counts/mg. Diphenyleneiodonium (DPI), an inhibitor 
of NADPH oxidase, significantly decreased the superoxide radical production induced 
by β-NADH (200 ± 25 counts/mg). The vehicle (0.1% DMSO) used to dissolve the 
extract did not have any effect on the O2
−
 production induced by β-NADH. The MPG 
extract dose-dependently reduced the O2
− stimulated by β-NADH with a significant 
decrease observed from the concentration 0.5 μg/ml to 50 μg/ml. 
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Figure 3.5: Effect of various concentration of Phoebe grandis (stem bark) methanolic 
extract on superoxide production induced by β-NADH in rat aortic rings detected by 
chemiluminescence assay. Superoxide production was inhibited in the presence of 
diphenyleneiodonium (DPI, 5 µM), an NADPH oxidase inhibitor. Results are mean ± 
SEM (n=5-7). * P < 0.01 compared to vehicle control. 
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3.5 Discussion 
The results from the present study shows that the stem bark of MPG exhibited: (1) a 
marked cellular antioxidant activity at the concentration range of 1-3 mg/ml and (2) 
improved endothelium-dependent relaxation by inhibiting NADH/NADPH oxidase 
stimulated superoxide production. In the cell-based assay, the intracellular antioxidant 
effects of the MPG extract protected the cells against the ROS, i.e. peroxyl radicals, 
induced by tBuOOH. One of the active components of MPG extract is boldine, an 
aporphine alkaloid, and known to possess potent peroxyl radical scavenging and poor 
superoxide scavenging functions (O'Brien et al., 2006). The cell-based assay reaffirms 
that the MPG extract posses free radical scavenging activity. Improved endothelium- 
dependent relaxation to ACh in response to oxidative stress induced by β-NADH and 
decreased tissue superoxide levels, suggests that MPG is able to scavenge peroxyl 
radicals as well as reduce the generation of superoxide radicals produced by 
intracellular NADH/NADPH oxidase. Accumulating evidence indicates that the 
generation of ROS is closely associated with the development of many cardiovascular 
diseases (Cai & Harrison, 2000). β-NADH has been commonly used to stimulate 
NADH/NADPH oxidase activity in vitro. Previous studies have indicated increased 
superoxide generation in vascular vessel preparations in response to application of 
exogenous NADH (Brandes et al., 1997; Didion & Faraci, 2002; Lund et al., 2000). In 
the present study, pre-incubation of the tissues with β-NADH markedly reduced the 
endothelium-dependent relaxation to ACh in the isolated rat aorta and partly the 
endothelium-independent relaxation to SNP. Stimulation of M3-muscarinic receptor by 
ACh releases NO from the endothelium which then diffuses into adjacent smooth 
muscle cells and leads to soluble guanylate cyclase (sGC) activation, cyclic GMP 
elevation and ultimately to vascular smooth muscle relaxation (Murad, 1986). SNP 
breaks down spontaneously to yield NO, thereby causing endothelium-independent 
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vasodilatation by the same effectors mechanism as NO released from endothelium (i.e. 
activation of sGC) (Murad, 1986). Increased production of O2
−
, leads to reduce released 
of NO and/or inactivation of NO released from the endothelium, and ultimately 
attenuating the ACh-induced relaxations and partly SNP-induced relaxation. Pre-
treatment with MPG significantly prevented β-NADH-induced attenuation of ACh 
relaxation in the rat aorta, suggesting the extract may increase the bioavailability of NO 
from the scavenging effects of the oxygen radicals. Furthermore, treatment with the 
extract in β-NADH treated aortas partly improved the relaxant responses and the 
sensitivity to endothelium-independent NO donor, SNP. This is indirect evidence that 
the beneficial effect of MPG on ACh-induced relaxation resides mainly improving the 
upstream endothelial NO bioavailability, since the extract only partly attenuated the 
downstream NO signal transduction pathway. Several studies have repeatedly shown 
that treatment with antioxidants improved endothelium-dependent relaxation in animal 
models of oxidative stress such as in spontaneously hypertensive rats (Machha & 
Mustafa, 2005; Vera et al., 2007). Many medicinal plants have also been found to cause 
endothelium-dependent relaxation in vascular tissues. Many are related to the balance 
between NO and O2
−
 (Achike & Kwan, 2003). In the present study, the MPG extract 
protected the cells against the oxidative stress effect of reactive oxygen radicals 
generated by tBuOOH. Boldine, an aporphine alkaloid is found in high concentrations 
in Phoebe grandis, and is known to possess potent antioxidative and free radical 
scavenging functions (Schmeda-Hirschmann et al., 2003). Thus, antioxidant actions of 
MPG may have increased the bioavailability of endothelium-derived NO, subsequently 
increasing the ACh-dependent relaxation. Both MPG and O2
− 
scavenger (superoxide 
dismutase, SOD) improved ACh-induced relaxation in β-NADH pre-treated tissues with 
an essentially similar magnitude. This indicates that MPG may be scavenging the β- 
NADH-induced superoxide productions in the rat aorta. However, in the presence of 
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pyrogallol, MPG failed to restore the NO-dependent relaxations. Pyrogallol, a pro-
oxidant auto-oxidizes in tissue bath medium to generate extracellular O2
−, while β-
NADH stimulates release of intracellular O2
− 
from NADH/NADPH oxidase activity 
(Didion & Faraci, 2002; Marklund & Marklund, 1974). This is suggesting that the 
protective effect of the extract does not involve scavenging of O2
− 
but somewhat affects 
the intracellular NADH/NADPH oxidase activity in endothelial cells or in the vascular 
smooth muscle cells. These hypotheses are further supported in which measurement of 
O2
− 
by lucigenin chemiluminesence assay demonstrated that MPG dose-dependently 
decreased O2
− production induced by β-NADH. This suggests that MPG may inhibit 
NADH/NADPH oxidase stimulated O2
−
 production in a similar manner to apocynin 
(Stolk et al., 1994). 
 
3.6 Conclusion 
In summary, results from the present study showed that MPG extract may have 
improved the magnitude of endothelial dependent and independent relaxations through 
its antioxidant activity (peroxyl radical scavenging) as well as inhibiting 
NADH/NADPH induced O2
−
 productions in endothelial cells or vascular smooth muscle 
cells. 
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CHAPTER IV 
THE APORPHINE ALKALOID BOLDINE IMPROVES ENDOTHELIAL 
FUNCTION IN SPONTANEOUSLY HYPERTENSIVE RATS 
 
4.1 Abstract 
Boldine, a major aporphine alkaloid found in Chilean boldo tree, is a potent antioxidant.  
Oxidative stress plays a detrimental role in the pathogenesis of endothelial dysfunction 
in hypertension.  In the present study, we investigated the effects of boldine on 
endothelial dysfunction in hypertension using spontaneously hypertensive rats (SHR), 
the most studied animal model of hypertension.   SHR and their age-matched 
normotensive Wistar-Kyoto (WKY) rats were treated with boldine (20 mg/kg per day) 
or its vehicle, which served as control, for 7 days.  Control SHR displayed higher 
systolic blood pressure (SBP), reduced endothelium-dependent aortic relaxation to 
acetylcholine (ACh), marginally attenuated endothelium-independent aortic relaxation 
to sodium nitroprusside (SNP), increased aortic O2
−
 and ONOO
− 
production, and 
enhanced p47
phox
 protein expression as compared to control WKY rats. Boldine 
treatment significantly lowered SBP in SHR but not in WKY.  Boldine treatment 
enhanced the maximal relaxation to ACh in SHR, but had no effect in WKY, whereas 
the sensitivity to ACh was increased in both SHR and WKY aortas.  Boldine treatment 
enhanced sensitivity, but was without effect on maximal aortic relaxation responses, to 
sodium nitroprusside in both WKY and SHR aortas. In addition, boldine treatment 
lowered aortic O2
−
 and ONOO
−
 production and downregulated p47
phox
 protein 
expression in SHR aortas, but had no effect in the WKY control. These results show 
that boldine treatment exerts endothelial protective effects in hypertension and is 
achieved, at least in part, through the inhibition of NADPH-mediated superoxide 
production.   
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4.2 Introduction 
Hypertension is the most important risk factor for cardiovascular disease, which is the 
leading cause of death and illness throughout the world (Lip et al., 2000). Endothelial 
dysfunction, which is mostly manifested as impairment in endothelium-derived nitric 
oxide (NO)-dependent vasodilation of blood vessels, represents a major risk factor for 
hypertension (Armitage et al., 2009; Gewaltig & Kojda, 2002)  Therefore, interventions 
that can restore endothelial function are likely to improve clinical outcome in 
hypertensive subjects.  One such intervention that received much attention in recent 
times is supplementation with “natural” antioxidants, confounded by the fact that 
increased production of reactive oxygen species (ROS) plays a critical role in the 
pathogenesis of endothelial dysfunction in hypertension (Ferroni et al., 2006; Schulz et 
al., 2008).
 
 
Boldine, an aporphine alkaloid, is a potent “natural” antioxidant found majorly in leaf 
and bark of the Chilean boldo (Peumus boldus Molina) tree (O'Brien et al., 2006; 
Speisky & Cassels, 1994).  In earlier studies, boldine has been demonstrated to have 
anti-inflammatory, antipyretic, anti-diabetic, anti-atherogenic, anti-platelet, anti-tumour 
promoting, and cytoprotective effects, which stem from its potent antioxidant actions 
(O'Brien et al., 2006).  For instance, treatment with boldine decreased artherogenic 
lesion formation and inhibited oxidation of low density lipoprotein in LDLR
-/-
 mice 
(Santanam et al., 2004). Apart from its antioxidant effects, boldine can also promote 
vascular smooth muscle relaxation (Ivorra et al., 1993b). However, to the best of our 
knowledge, no studies at this point in time have demonstrated the effects of boldine in 
hypertension. This study, therefore, evaluated the effectiveness of boldine in the 
treatment of endothelial dysfunction in spontaneously hypertensive rats (SHR), the most 
studied experimental model of hypertension.  Our own interest in boldine arose from the 
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observation that 1) it is widely found in the bark of local tree Phoebe grandis and 2) 
boldine-containing herbal teas are widely consumed around the world, in particular in 
South America (O'Brien et al., 2006).
 
 
4.3 Materials and methods 
4.3.1 Drugs and chemicals 
Acetylcholine chloride (ACh), serotonin hydrochloride, bis-N-methylacridinium nitrate 
(lucigenin), diethyldithiocarbamate acid (DETCA), diphenyliodonium (DPI), β-
nicotinamide adenine dinucleotide phosphate (NADPH), 5-amino-2,3-dihydro-1,4-
phthalazinedione (luminol), boldine, uric acid and Tris-base were purchased from 
Sigma chemicals company (St. Louis, MO, USA). Bovine serum albumin (BSA) and 
Tween-20 were purchased from Bio-Rad Laboratories (Hercules, CA, USA). Sodium 
nitroprusside (SNP) and Kreb’s salts were purchased from BDH Limited and BDH 
Laboratory Supplies (Poole, UK), respectively.  
 
4.3.2 Animals and experimental protocol 
Male spontaneously hypertensive (SHRs) and Wistar-Kyoto (WKYs) rats (17-18 weeks 
old) were obtained from the University of Malaya Animal Unit, and all the experimental 
procedures were approved by the University of Malaya Animal Care and Ethics 
Committee. The animals were housed in a well ventilated room (temperature: 24 ± 1°C), 
and had free access to standard rat chow and tap water. The rats were randomised to 
receive boldine vehicle (20 % tween 80), which served as control, or boldine (20 mg/kg).  
The treatments were given by intraperitoneal injection, once daily for 7 days.  To avoid 
the possible involvement of acute effects of the treatment, all the post-treatment 
experiments were conducted at least 24 h after the final treatment.   
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4.3.3 Non-invasive measurement of blood pressure 
Systolic blood pressure was measured prior to and after the treatment period by tail-cuff 
plethysmography (NIBP machine, IITC Inc. CA, USA).  Blood pressure values for 
individual rats were obtained from the average of eight consecutive measurements and 
were monitored in the morning at the same period of the time of the day. 
 
4.3.4 Measurement of ex vivo vascular function 
After measurement of blood pressure, the rats were anaesthetized with a single 
intraperitoneal dose of pentobarbitone sodium (60 mg/kg body weight) and sacrificed 
by cervical dislocation.  Thereafter, the descending thoracic aorta was rapidly removed 
and cleaned of fat and connective tissues.  The aortas were sectioned into small rings (3-
5 mm in width) and placed in jacketed organ baths (one ring in each bath) containing 5 
ml of Krebs physiological salt solution (KPSS) composed of (mM): NaCl 118.2, 
NaHCO3 25.0, KCl 4.7, KH2PO4 1.2, MgSO4.7H2O 1.2, glucose 11.7, CaCl2.2H2O 2.5 
and EDTA 0.026.  The bath solution was maintained at 37 °C and aerated continuously 
with a mixture of 95% O2 and 5% CO2. The rings were connected to isometric force-
displacement transducers (Grass Instrument Co., Quincy, MA, USA) and the output was 
amplified and recorded continuously using the Mac Lab recording system (AD 
Instruments, Sydney, Australia). The rings were equilibrated for 45 min under 1.0 g 
resting tension.  After the equilibration period, the contractile responses of aortic rings 
were tested for viability by the repeated addition of high KCl solution (high K
+
, 80 mM).  
Once reproducible contractions were obtained with high K
+
, the aortic rings were 
contracted with serotonin (30 µM) and the concentration-response curves to 
endothelium-dependent and -independent vasodilators, acetylcholine (ACh, 0.1 nM to 
10 µM) and sodium nitroprusside (SNP, 0.01 nM to 1 µM), respectively, were recorded.  
Acetylcholine or sodium nitroprusside was added cumulatively at 3-min intervals 
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between successive doses.  The choice of serotonin over more conventionally used 
phenylephrine to test the relaxation responses to ACh and SNP was prompted by earlier 
investigations which demonstrated that boldine may interact with α1-adrenoceptors and 
Ca
2+
 channels (Chulia et al., 1996; Ivorra et al., 1993a). 
 
4.3.5 Measurement of superoxide anion production 
 Levels of O2
-
 production from aortas isolated from different groups of rats were 
measured using the lucigenin-enhanced chemiluminescence (LEC) method with a 
luminometer (CHAMELEON™ V, Hidex, Turku, Finland) (Woodman & Malakul, 
2009). After clearing of fat and connective tissues, aortic rings were rinsed in Krebs-
HEPES buffer [composition in mM: NaCl 99.0, NaHCO3 25, KCl 4.7, KH2PO4 1.0, 
MgSO4.7H2O 1.2, glucose 11.0, CaCl2.2H2O 2.5 and Na-HEPES 20.0] and incubated 
for 45 min at 37 °C in the presence and absence of diphenylene iodonium (DPI, 5 μM), 
a NADPH oxidase inhibitor, in Krebs-HEPES buffer containing 1 mM 
diethylthiocarbamic acid (DETCA) and 0.1 mM β-nicotinamide adenine dinucleotide 
phosphate (NADPH).  After the incubation period, the rings were washed with Krebs-
HEPES buffer and transferred to a 96-well plate with one ring in each well containing 
of 300 µl Krebs-HEPES buffer with lucigenin (5 μM) and NADPH (0.1 mM). The plate 
was immediately loaded into a luminometer and the output of LEC was recorded. 
Thereafter, the rings were dried for 48 h at 65 °C and weighed.  The levels of 
superoxide generation were normalized to milligrams dry weight of tissue.  
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4.3.6 Measurement of peroxynitrite production 
 Levels of ONOO
−
 production from aortas isolated from different groups of rats were 
measured using the luminol-enhanced chemiluminescence method with a luminometer 
(CHAMELEON™ V, Hidex, Turku, Finland) (Radi et al., 1993).  This method is 
similar to that used for superoxide detection (section 4.3.5) with the exceptions that 1) 
luminol (100 µM) is used instead of lucigenin and 2) aortic rings were incubated in 
Krebs-HEPES buffer containing 1 mM DETCA and 0.1 mM NADPH in the presence 
and absence of uric acid (250 mM), a scavenger of ONOO
−
.  
 
4.3.7 Measurement of p47
phox
 protein expression 
Aortas isolated from different groups of rats were freezed in liquid nitrogen and stored 
at -80 ºC until analyzed. Aortas were homogenized in ice-cold 1X RIPA buffer (Santa 
Cruz Biotechnology, CA, USA) by using gentleMACS
TM
 dissociator (Miltenyi biotec 
Inc., Bergisch Gladbach, Germany). The lysates were then centrifuged and supernatants 
were collected for Western blotting. Protein concentrations of the supernatant were 
determined by Bradford assay.  For each sample, 30 µg of total tissue protein was 
separated in 10% sodium dodecyl sulphate (SDS)-polyacrylamide gel and transferred to 
nitrocellulose membranes at 100 V for 90 min.  The blots were blocked for non-specific 
binding with 3% bovine serum albumin (BSA) in Tris-buffered saline containing 0.1% 
Tween 20 (TBS-T) for 1 h at room temperature with gentle shaking. It was then washed 
three times with TBS-T and incubated overnight at 4 ºC with primary mouse 
monoclonal antibody (1:500 dilution, Santa Cruz Biotechnology, CA, USA). The 
membranes were washed three times for 5 min in TBS-T and incubated with secondary 
goat anti-mouse antibody conjugated to horseradish peroxidise for 1 h at room 
temperature. After extensive washing of the membrane, the bands were detected using 
3,3′,5,5′-Tetramethylbenzidine (TMB) liquid substrate system (Sigma, St. Louis, MO, 
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USA). The membrane image was captured under Gel DOC XR system (Bio-Rad 
Laboratories, Hercules, CA, USA) and densitometric analysis was performed using 
Quantity One® 1-D analysis software.  The p47
phox
 protein expression levels were 
normalized to α-actin and data are expressed as a percentage of the values in WKY 
control group. 
 
4.3.8 Statistical analysis 
All results are presented as mean ± standard error of mean (SEM) for number (n) of rats 
in each experimental group. Concentration-response curves were fitted to a sigmoidal 
curve using non-linear regression with the aid of the statistical software GraphPad 
Prism version 4, USA. Agonist sensitivity (pEC50) and maximal response (Rmax) for 
each group were obtained from the curves. The observed responses were analyzed for 
statistical significance using Student’s t-test for unpaired observations and the one-way 
analysis of variance (ANOVA) followed by Bonferroni’s multiple comparison test for 
multiple value comparison (Prism 2.0, GraphPad Software, USA). A value of P < 0.05 
was considered statistically significant.    
 
4.4 Results 
4.4.1 Effect of boldine treatment on blood pressure 
Table 4.1 summarizes the mean ± SEM values for systolic blood pressure in different 
groups of animals. Systolic blood pressure was elevated in SHR animals compared with 
WKY animals.  Boldine treatment (20 mg/kg per day, i.p) had no significant effect on 
systolic blood pressure of WKY rats, but significantly lowered it in SHR animals.  
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Table 4.1: Pre- and post-treatment systolic blood pressure (SBP) among vehicle- 
(control) or boldine-treated Wistar-Kyoto rats (WKY) and spontaneously hypertensive 
rats (SHR) 
 
Systolic Blood Pressure (mm Hg)  
Experimental group  Before  After  
WKY-control  104.6 ± 2.37  110.8 ± 1.87  
WKY-boldine  107.1 ± 3.40  111.6 ± 2.91  
SHR-control    190.2 ± 2.92 *  192.4 ± 1.97  
SHR-boldine  193.5 ± 1.23  166.9 ± 1.44 #  
 
Data are expressed as mean ± SEM (n =6–7) 
* P < 0.001 compared with WKY-control 
# P < 0.001 compared with SHR-control 
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4.4.2 Effect of boldine treatment on vascular function 
Figure 4.1 depicts the relaxation responses to ACh (panel A) and SNP (panel B) in 
aortic rings isolated from vehicle (control)- or boldine-treated WKY and SHR animals. 
Aortic rings from control SHR in general showed lesser relaxation responses to ACh 
and SNP compared to respective responses in control WKY aortic rings (Figure 4.1 and 
Table 4.2).  Aortic rings from boldine-treated WKY and SHR animals demonstrated 
enhanced sensitivity to ACh and SNP compared to equivalent responses in respective 
control rats (Table 4.2).  Maximal relaxation response to ACh was markedly increased 
in aortic rings obtained from boldine treated SHR compared with control SHR aortic 
rings, but remain essentially similar in the control and boldine-treated WKY rings 
(Table 4.2).   Maximal relaxation response to SNP remains unaltered in aortic rings 
from boldine treated WKY and SHR animals compared with equivalent responses 
observed in respective control rats (Table 4.2).    
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Figure 4.1: Chronic boldine treatment (20 mg/kg) improves endothelial function in aorta 
of SHR rats. (A) The representative traces showing the impairment of ACh-induced 
endothelium-dependent relaxation in SHR aorta that were restored by chronic treatment 
of boldine (B) The summarized graph shows that chronic boldine treatment improved 
ACh-induced endothelium-relaxation in SHR rat aorta (C) SNP-induced endothelium-
independent relaxations were not altered by all groups of treatment. Data are expressed 
as mean ± SEM (n= 6-7). # P < 0.001 compared to WKY-control, * P < 0.001 compared 
to SHR-control. 
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Table 4.2: Agonist sensitivity (pEC50) and % maximum response (Rmax) of endothelium-
dependent and -independent vasodilators acetylcholine (ACh) and sodium nitroprusside 
(SNP), respectively, in aortic rings isolated from control and boldine-treated Wistar-
Kyoto rats (WKY) and spontaneously hypertensive rats (SHR) 
 
Data are expressed as mean ± SEM (n = 6–7) 
* P < 0.001 compared with WKY-control 
# P < 0.05 compared with WKY-control 
†P < 0.00l compared with SHR-control 
 
 
 
 
 
 
 
 
 
ACh 
 
SNP 
Group  
pEC50 
 (log M) 
Rmax (%) 
 pEC50  
 (log M) 
Rmax (%) 
WKY- control  6.52 ± 0.48  88.44 ± 1.85  
 
8.01 ± 0.23  100.50 ± 4.90  
WKY- boldine  7.68 ± 0.21 
#
  90.38 ± 3.05  
 
8.37 ± 0.07
  #
  109.67 ± 2.74  
SHR - control  7.96 ± 0.12  40.60 ± 5.64 
*
  
 
7.61 ± 0.55  102.00 ± 1.97  
SHR- boldine  8.28 ± 0.13† 94.67 ± 5.28 †  
 
8.47 ± 0.20 
 †  106.80 ± 4.00  
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4.4.3 Effects of boldine treatment on superoxide anion production  
Levels of O2
− 
generation in aortic rings from vehicle or boldine-treated WKY and SHR 
rats are shown in Figure 4.2.  Superoxide levels were increased in control SHR aortas 
compared with control WKY aortas, and this increase was totally abolished in the 
presence of DPI, a NADPH oxidase inhibitor (Figure 4.2).  There were no significant 
differences in superoxide generation between control and boldine-treated WKY rat 
aortas.  Aortas from SHR treated with boldine demonstrated significant reduction in 
superoxide generation compared with control SHR aortas.  There were no significant 
difference observed in superoxide generation from control and boldine-treated WKY 
and SHR aortas in the presence of DPI (Figure 4.2).  
 
4.4.4 Effects of boldine treatment on peroxynitrite production 
 Levels of ONOO
−
 generation in aortic rings from vehicle- or boldine-treated WKY and 
SHR rats are shown in Figure 4.3.  Peroxynitrite levels were increased in control SHR 
aortas compared with control WKY aortas, and this difference was completely 
abolished in the presence of ONOO
−
 scavenger, uric acid (Figure 4.3).  There were no 
significant differences in ONOO
−
 generation between control and boldine-treated WKY 
rat aortas. Aortas from SHR treated with boldine demonstrated significant reduction in 
ONOO
−
 generation compared with control SHR aortas.  There was no significant 
difference observed in ONOO
−
 generation from control and boldine-treated WKY and 
SHR aortas in the presence of uric acid (Figure 4.3).  
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Figure 4.2: Levels of superoxide anion (O2
−
) generation in aortic rings from control and 
boldine treated Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR).  
Results are shown as mean ± SEM (n = 8-10), # P < 0.001 compared to WKY-control, * 
P < 0.01 compared to SHR-control. 
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Figure 4.3: Levels of peroxynitrite (ONOO
−
) generation in aortic rings from control and 
boldine treated Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR).  
Results are mean ± SEM (n = 4-6). # P < 0.01 compared to WKY-Control, * P < 0.01 
compared to SHR-Control.  
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4.4.5 Effects of boldine treatment on p47
phox
 protein expression  
The p47
phox 
protein expression was significantly higher in control SHR aortas as 
compared to control WKY aortas (Fig 4.4). Boldine treatment significantly reduced 
p47
phox
 protein expression in SHR but had no effect in WKY (Fig 4.4).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4: Protein expression levels of p47
phox 
in aortic rings from control and boldine 
treated Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR). Results 
are mean ± SEM. (n = 4) of densitometric values normalized to corresponding α-actin 
and expressed as a percentage of WKY-control. # P < 0.05 compared to WKY-Control, 
* P < 0.01 compared to SHR-Control.  
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4.5 Discussion 
The present study investigated, for the first time, the effects of boldine treatment (20 
mg/kg per day) on endothelial dysfunction in hypertension.  The novel findings of the 
present study are that boldine treatment improved impaired endothelial-dependent 
vasorelaxation in SHR aortas. In addition, boldine treatment also decreased O2
-
 and 
ONOO
-
 levels and p47
phox 
protein expression in SHR aortas. Furthermore, boldine 
treatment decreased systolic blood pressure in SHR.  Collectively, these findings 
suggest an apparent protective role for boldine in the treatment of endothelial 
dysfunction in hypertension.  
 
The present results demonstrated that boldine treatment significantly reduced mean SBP 
in SHR (Table 4.1).  While the possibility of a direct vasodilator effect of boldine could 
be entertained in this phenomenon, this appears unlikely as blood pressure 
measurements were recorded at least 24 h after the final treatment with boldine.  
Scavenging of endothelium-derived NO by increased O2
−
, leading to inadequate NO 
concentrations and to increased formation of ONOO
−
, can contribute to the diminished 
role of NO in the regulation of blood pressure in hypertension (Endemann & Schiffrin, 
2004).  Indeed, despite some paradoxical findings, several studies have shown that 
treatment with antioxidants such as ascorbic acid reduced blood pressure in humans and 
in animal models of hypertension including SHR (Akpaffiong & Taylor, 1998; Fujii et 
al., 2003; Laursen et al., 2001; Virdis et al., 2004). In the present study, boldine 
treatment reduced O2
−
/ONOO
−
 production in SHR, suggesting that by 
inhibiting/decreasing O2
−
,
 
boldine reduced blood pressure in SHR.  A superoxide 
decreasing role for boldine in reduced blood pressure in SHR also gains ground from 
the finding that boldine treatment failed to alter blood pressure in normal WKY rats in 
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which the vascular O2
−
 production is expected to be too little (or even negligible) to 
effect the regulatory functions of endothelium-derived NO.   
 
Impaired endothelium-dependent relaxations have been observed in different animal 
models of hypertension including SHR (Lyle & Griendling, 2006; Schulz et al., 2008; 
Suzuki et al., 1995; Ungvari et al., 2004).
 
 Consistent with these reports, the results of 
the present study demonstrated that endothelium-dependent relaxation responses to 
acetylcholine were significantly lesser in SHR aortas compared to their WKY 
counterparts (Figure 4.1A and 4.1B).  Present results also demonstrate that treatment 
with boldine significantly improved endothelium-dependent relaxation responses to 
acetylcholine in SHR aortas (Figure 4.1A and 4.1B), indicating improvement in 
endothelial function in these hypertensive animals.   One important mechanism for 
impaired endothelium-dependent relaxations in SHR is increased production of O2
−
 
(Schulz et al., 2008).  Superoxide anion reacts with endothelium-derived NO to form 
ONOO
-
, leading to impaired endothelium-dependent relaxations in hypertension 
(Schulz et al., 2008). Boldine is a potent antioxidant, as evidenced by inhibition of O2
− 
and other ROS in earlier studies (Estelles et al., 2005; Jang et al., 2000; O'Brien et al., 
2006).  For example, in an earlier study, we have shown that boldine inhibited peroxyl 
radical formation in cell-free xanthine/xanthine oxidase superoxide generation system 
(Lau et al., 2010). In the present study, boldine treatment significantly attenuated O2
−
 
and ONOO
−
 production in SHR aortas (Figure 4.2 and Figure 4.3). In addition, boldine 
treatment also decreased p47
phox
 protein expression in SHR aortas.  It is well known that 
p47
phox 
regulates the activity of nicotinamide adenine dinucleotide phosphate 
(NADPH)-dependent oxidases, which play a major role in increased O2
−
 production in 
hypertensive vasculature. NADPH oxidase is a mutlicomponent enzyme that comprises 
a membrane-bound cytochrome b558 (p22
phox
 and gp91
phox
) and regulatory cytosolic 
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proteins (p47
phox 
and p67
phox
) which has been found in membranes of all vascular cells 
including endothelial cells, vascular smooth muscle cells and fibroblasts (Forstermann, 
2008; Guzik & Harrison, 2006). By inhibiting NADPH-mediated production of O2
−
 in 
both endothelial cells and smooth muscle cells, NO bioavailability can be improved, 
which helps in vasorelaxation. Putting together, these observations suggest that boldine 
treatment  improves endothelial function in SHR at least in part through  inhibition of 
NADPH-mediated O2
−
 production and subsequently improving endothelial NO 
bioavailability. In support to this, boldine treatment enhanced total plasma nitrite/nitrate 
(NOx) levels in SHR but not in WKY rats (Appendix B).  
 
Interestingly, in the present study we found that aortic rings from boldine-treated WKY 
rats demonstrated higher sensitivity to acetylcholine-induced relaxation compared to 
control WKY aortas.  This improvement in WKY aortas, as argued above, cannot be 
attributed to antioxidant activity of boldine. This is because boldine treatment had no 
effect on O2
−
 and ONOO
−
 production in WKY aortas (Figure 4.2 and Figure 4.3).  In 
addition, normotensive WKY tissues produce little or no free radicals (Ajay et al., 
2006a; Katusic, 1996).  In earlier studies, boldine had been reported to elicit smooth 
muscle-relaxing effects, which may well contribute to improved relaxation to 
acetylcholine observed in the present study (Ivorra et al., 1993a).  However, with the 
vascular reactivity studies performed at least 24 h after the final day treatment, this 
possibility is unlikely.   On the other hand, however, boldine treatment improved the 
sensitivity of WKY aortic rings to the endothelium-independent vasodilator, SNP 
(Figure 4.1B), thus supporting the view that boldine improved the sensitivity of WKY 
aortas to ACh.  Both ACh and SNP cause smooth muscle relaxation by the same effect 
or mechanism with the exception that acetylcholine-induced relaxation requires release 
of NO from the endothelium whereas SNP breaks down spontaneously to release NO 
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independently of the endothelium (Hansen & Nedergaard, 1999; Murad, 1986).  Once 
released, NO diffuses into adjacent smooth muscle cells and leads to soluble guanylate 
cyclase (sGC) activation, cGMP elevation and ultimately to vascular smooth muscle 
relaxation (Hansen & Nedergaard, 1999; Murad, 1986).  Putting these observations 
together, it appears that the effects of boldine not only reside upstream of the NO-sGC-
cGMP cascade (i.e., preservation of NO bioavailability) but also reside downstream the 
NO-sGC-cGMP cascade (i.e., enhancement in the cGMP accumulation and NO 
bioactivity).  The direct measurement of cGMP production which we were unable to 
perform in this study will be useful in further clarifying these assumptions.  
 
Lastly, in the present study, despite normalizing oxidative stress parameters, boldine 
treatment failed to completely normalize the elevated blood pressure in SHR.  The exact 
mechanism(s) of this discrepancy is unclear; but, however, it is noteworthy to mention 
that several oxidative stress-independent factors perse alterations in sympathetic 
nervous system can also contribute to development of hypertension in SHR.  On the 
other hand, it is also important to note that, whereas all the above observations suggest 
the possibility that by decreasing O2
−
 boldine reduced blood pressure and improved 
endothelium-dependent relaxations in SHR, present findings neither support nor rule out 
a role for other actions of boldine perse anti-inflammatory actions in its observed effects.   
 
4.6 Conclusion 
In summary, the present results show that boldine treatment improves endothelial 
function in SHR in part by inhibiting NADPH-mediated superoxide production. The 
present results point to a potential therapeutic use for boldine in the management of 
elevated blood pressure and endothelial dysfunction in hypertension.  
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CHAPTER V 
BOLDINE PROTECTS ENDOTHELIAL FUNCTION IN HYPERGLYCAEMIA-
INDUCED OXIDATIVE STRESS THROUGH AN ANTIOXIDANT 
MECHANISM 
 
5.1 Abstract 
Increased oxidative stress is involved in the pathogenesis and progression of diabetes. 
Antioxidants are therapeutically beneficial for oxidative stress-associated diseases. 
Boldine ([s]-2,9-dihydroxy-1,10-dimethoxyaporphine) is a major alkaloid present in the 
leaves and bark of the boldo tree (Peumus boldus Molina), with known antioxidant 
activity. This study examined the protective effects of boldine against high glucose-
induced oxidative stress in rat aortic endothelial cells (RAEC) and its mechanisms of 
vasoprotection related to diabetic endothelial dysfunction. In RAEC exposed to high 
glucose (30 mM) for 48 h, pre-treatment with boldine reduced the elevated ROS and 
nitrotyrosine formation, and preserved nitric oxide (NO) production. Pre-incubation 
with β-NAPDH reduced the acetylcholine-induced endothelium-dependent relaxation; 
this attenuation was reversed by boldine. Compared with control, endothelium-
dependent relaxation in the aortas of streptozotocin (STZ)-treated diabetic rats was 
significantly improved by both acute (1 µM, 30 min) and chronic (20 mg/kg/daily, i.p., 
7 days) treatment with boldine. Intracellular O2
−
 and ONOO
−
 formation measured by 
DHE fluorescence or chemiluminescence assay were higher in sections of aortic rings 
from diabetic rats compared with control. Chronic boldine treatment normalized ROS 
over-production in the diabetic group and this correlated with reduction of NAD(P)H 
oxidase subunits, NOX2 and p47
phox
. The present study shows that boldine reversed the 
increased ROS formation in high glucose-treated endothelial cells and restored 
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endothelial function in STZ-induced diabetes by inhibiting oxidative stress and thus 
increasing   NO bioavailability.  
 
5.2 Introduction 
Endothelial dysfunction is correlated with hypertension, arteriosclerosis, diabetes and 
chronic heart failure (Schulz et al., 2008). It is defined as impairment of endothelium-
dependent relaxation and the major factor contributing to this condition is the 
compromised nitric oxide-cyclic GMP (NO-cGMP) signalling (Armitage et al., 2009). 
Excessive production of reactive oxygen species (ROS) interferes with NO signalling 
and thus plays a pivotal role in the development of vascular complications in diabetes 
(Armitage et al., 2009).  
 
Over the past few decades, hyperglycaemia-induced oxidative stress has been 
increasingly known as a hallmark in diabetic vasculature through several mechanisms 
such as activation of protein kinase C, polyol pathway and formation of advanced 
glycation end-product (Choi et al., 2008). Hyperglycaemia causes the excessive ROS 
formation, particularly O2
−
, a radical that result from the reaction of oxygen with a 
single electron (Jay et al., 2006; Johansen et al., 2005a). NAD(P)H oxidase, a multi-
subunit enzymatic complex, is the major enzymatic sources of superoxide generation in 
vascular cells (Kalinowski & Malinski, 2004). Excess O2
− 
can react with nitric oxide, 
forming the toxic ONOO
−
, which in turn uncouples enzymatic nitric oxide synthase 
(eNOS) by oxidizing the essential NOS redox-sensitive co-factor tetrahydrobiopterin 
and causes eNOS to produce more O2
−
 (Schulz et al., 2008). This continuous cascade of 
events reduces the bioavailability of NO and eventually leads to endothelial dysfunction 
in diabetes (Li et al., 2003). 
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Boldine ((S)-2,9-dihydroxy-1,10-dimethoxy-aporphine) is an aporphine alkaloid found 
abundantly in the leaves/bark of boldo (Peumus boldus Molina), a widely distributed 
tree native to Chile. Boldine is also one of the major alkaloids in the bark of a local tree 
of Phoebe grandis found in the Northern part of Peninsular Malaysia (Yeh-Siang et al., 
2011). Boldine has been reported to have several pharmacological activities, such as 
anti-inflammatory, antipyretic, antidiabetic, antiatherogenic, antiplatelet, antitumor 
promoting and cytoprotective effects (O'Brien et al., 2006). The action of boldine has 
been attributed to its antioxidant activity as it prevents lipid peroxidation in human liver 
microsomes (Kringstein & Cederbaum, 1995), and scavenges hydroxyl radicals (Jang et 
al., 2000). In addition, boldo extracts (Peumus boldus) has been demonstrated in several 
studies to have anti-inflammatory properties via its ability to interfere with the 
generation of free radical (Backhouse et al., 1994; Milian et al., 2004). The methanolic 
extract of Phoebe grandis of which boldine, is a major compound, was shown to 
effectively improve the endothelium-dependent relaxations that were diminished by 
oxidative stress (Yeh-Siang et al., 2011). Although the antioxidant activities of boldine 
have been extensively studied, it has not been correlated with the hyperglycaemia-
induced oxidative stress and improving endothelial dysfunction in diabetic animals. 
Therefore, this study aims to investigate the effect of boldine in abating high glucose-
induced ROS formation and improving endothelial dysfunction in streptozotocin-
induced diabetic rats. 
 
5.3. Materials and methods  
5.3.1 Chemicals and materials 
Acetylcholine (ACh) chloride, sodium nitroprusside (SNP), serotonin hydrochloride, 
bis-N-methylacridinium nitrate (lucigenin), diethylthiocarbamic acid (DETCA), 
diphenylene iodonium (DPI), β-NADPH, 5-amino- 2,3-dihydro-1,4-phthalazinedione 
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(luminol), boldine, uric acid, D-(+)-glucose, D-mannitol, triton-X, Hepes, citrate buffer, 
Tween-80 and Tris-base were purchased from Sigma Chemicals Company (St Louis, 
MO, USA). Bovine serum albumin (BSA) and Tween-20 were purchased from Bio-Rad 
Laboratories (Hercules, CA, USA). Kreb’s salts were purchased from BDH Limited and 
BDH Laboratory Supplies (Poole, UK), respectively. RPMI 1640 media, fetal bovine 
serum (FBS), penicillin and streptomycin were purchased from Gibco (invitrogen, CA, 
USA). Tempol was purchased from Tocris (Bristol, UK). 
 
5.3.2 Primary culture of rat aortic endothelial cells 
Primary aortic endothelial cells were isolated from adult Sprague Dawley (SD) rats and 
cultured as previously described (Tian et al., 2012b). Briefly, the aorta was isolated 
from the abdominal cavity of the rat after CO2 inhalation. The fat and connective tissues 
of the rat aorta was cleaned and placed in sterile ice-cold PBS. The aorta was then 
digested with filtered collagenase type 1A (Sigma, MO, USA) solution at 37 °C for 10 
min with gentle shaking. After incubation the cells were centrifuged at 1500 rpm for 10 
min and re-suspended in RPMI-1640 containing 10% FBS plus 100 U/ml penicillin and 
100 μg/ml streptomycin. After 1 h incubation at 37 °C, the medium was removed and 
replaced to eliminate the smooth muscle cells. The endothelial cells were incubated in a 
humidified atmosphere containing 5% CO2 at 37 °C until the cells reached 80% 
confluence. The identity of RAECs was confirmed by a positive immunofluorescence 
staining of PECAM-1 (Santa Cruz, CA, USA). 
 
5.3.3 Measurement of intracellular ROS generation 
The amount of intracellular ROS generation was measured with CM-H2DCFDA 
fluorescein (Invitrogen, CA, USA) dye that performed under Olympus FV1000 laser 
scanning confocal system (Olympus, America Inc., Melville, NY, USA). Intracellular 
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ROS was detected once CM-H2DCFDA oxidized to a fluorescent DCF product within 
the cell. In brief, the isolated primary rat endothelial cells were seeded on circular cover 
slip and the cells were incubated in normal glucose (NG, 5 mM glucose and 25 mM 
mannitol as osmotic control of HG) or co-treated with or without boldine (1 μM) in high 
glucose condition (HG, 30 mM) for 48 h. Tempol (100 µM), a superoxide dismutase 
(SOD) mimetic compound was added in the co-cultured as a positive control. At the end 
of treatment, the cells seeded on the circular cover slips were rinsed twice with normal 
physiological saline solution (NPSS in mM: NaCl 140, KCl 5, CaCl2 1, MgCl2 1, 
glucose 10 and HEPES 5) and then incubated at 37 °C for 20 min with CM-H2DCFDA 
(1 μM). The fluorescence intensity was analyzed using Olympus Fluoview version 1.6 
software. 
 
5.3.4 Detection of nitrotyrosine by immunofluorescence  
The confluent cells seeded on coverslip were fixed with 4% formaldehyde for 30 min. 
The cells were then permeabilized with 0.01% Triton-X 100 and blocked in 5% normal 
donkey serum (Jackson ImmunoResearch Laboratories, PA, USA) for 1 h. The cells 
were incubated with mouse anti-nitrotyrosine (1:20; Milipore, MA, USA) overnight at 
4 °C. After that, the cells were washed with PBS and incubated with Alexa® Fluor 488-
conjugated goat-anti-mouse secondary antibody (1:500; Invitrogen, CA, USA) for 2 h. 
At the end of incubation, the cells were stained with propidium iodide (1:3000; Sigma, 
MO, USA) to visualize the nucleus. The images were captured under Olympus FV1000 
laser scanning confocal system (Olympus, America Inc., Melville, NY, USA) and the 
immunofluorescence intensity was analyzed using Olympus Fluoview version 1.6 
software. 
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5.3.5 Detection of NO production in cultured endothelial cells 
The experiment was performed as previously described (Yuen et al., 2011). Basically, 
the confluent endothelial cells were seeded on the coverslip and followed by high 
glucose treatment as described in previous section. At the end of treatment, the cells 
were rinsed with NPSS and incubated with 10 μM DAF-FM diacetate (Invitrogen, CA, 
USA) for 10 min at 37 °C. NO productions in response to ACh (10 μM) were measured 
by the level of fluorescence intensity change which were detected under Olympus 
Fluoview FV1000 laser scanning confocal system (Olympus America, Inc., Melville, 
NY, USA) mounted on an inverted IX81 Olympus microscope with excitation at 495 
nM and emission at 515 nM. The real-time changes in intracellular fluorescence 
intensity were measured for 15 min and the results were presented as a ratio of 
fluorescence relative to intensity (F1/F0) before and after addition of ACh. 
 
5.3.6 Induction of diabetes and chronic treatment  
Male Sprague-Dawley (SD) (9-10 weeks old) were obtained from the University of 
Malaya Animal Unit, and housed in a well-ventilated room (temperature: 24 ± 1 °C), 
and had free access to standard rat chow (Specialty Feeds Pty Ltd, Glen Forrest, 
Australia) and tap water. All the experimental procedures were approved by the 
University of Malaya Animal Care and Ethics Committee. Diabetes mellitus were 
induced in 10-11 weeks SD rats (200-250 g) by injecting a single dose of 60 mg/kg 
streptozotocin (STZ) freshly dissolved in 0.1 M citrate buffer intraperitoneally. Blood 
glucose levels were measured using an Accu-check monitor (Roche, Mannheim, 
Germany) 3 days after diabetes induction. The animals were considered diabetic if the 
blood glucose level exceeds 17 mmol/l. After 8 week of induction, the rats were injected 
intraperitoneally with boldine (20 mg/kg/day) or vehicle (20% Tween 20) for 7 days. 
Body weights and blood glucose levels were recorded. 
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5.3.7 Measurement of lipids 
Total cholesterol, triglycride, HDL and non HDL were determined using the assay kit 
purchased from BioAssay System, CA, USA (EnzyChrom
TM
 AF Cholesterol Assay Kit; 
EnzyChrom
TM
 Triglyceride Assay kit; EnzyChrom
TM
 AF HDL and LDL/VLDL Assay 
Kit, E2HL-100). All assays were done according to the manufacture instructions. 
 
5.3.8 Preparation of aortic rings 
At the end of 7 days treatment, the rats were anesthetized with single intraperitoneal 
dose of pentobarbitone sodium (60 mg/kg body weight). The descending thoracic aorta 
was isolated and cleaned from surrounding fat and connective tissues. The aorta was cut 
into rings segments, 3-5 mm long and placed in oxygenated Krebs physiological salt 
solution (KPSS in mM: NaCl 119, NaHCO3 25, KCl 4.7, KH2PO4 1.2, MgSO4.7H2O 
1.2, glucose 11.7, and CaCl2.2H2O 2.5) and some tissues were snap frozen in liquid 
nitrogen and stored in -80 °C for protein analysis. The fresh aortic rings were 
maintained at 37 °C and stretched to optimal tension of 9.82 mN in a Multi Wire 
Myograph System (Danish Myo Technology, Aarhus, Denmark) and continuously 
oxygenated with 95% O2 and 5% CO2, and the changes of isometric tension in response 
to different drugs were recorded using the PowerLab LabChart 6.0 recording system 
(AD Instruments, Australia). The rings were equilibrated for 45 min before being 
repeatedly stimulated with high KCl solution (high K
+
, 80 mM) three times at 4 min 
intervals to prime the tissues until two consecutive equal contractions were attained. 
The presence of functional endothelium in pre-contracted aortic rings was confirmed by 
a relaxant response to acetylcholine (ACh, 10 µM).  Thereafter, concentration-
relaxation curves of the endothelium-dependent relaxant, (ACh, 0.1 nM - 10 µM) and of 
the endothelium-independent relaxant, sodium nitroprusside (SNP, 0.01 nM - 1 µM) 
were carried out on 5-HT-precontracted aortic rings. 
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5.3.9 In situ detection of vascular superoxide production by laser confocal 
fluorescence microscopy 
The amount of the in situ vascular superoxide formation was determined with using 
dihydroethidium (DHE, invitrogen, CA, USA) dye and Olympus FV1000 laser scanning 
confocal system (Olympus, America Inc., Melville, NY, USA) as described previously 
(Tian et al., 2011). Briefly, aortic rings from the respective groups were frozen in OCT 
compound (Sakura Finetek, Netherland) and 10 μm frozen cross sections were obtained. 
The sections were incubated in dark for 15 min in normal physiological saline solution 
containing 5 μM DHE fluorescence dye (NPSS: NaCl 140, KCl 5, CaCl2 1, MgCl2 1, 
glucose 10 and HEPES 5 mM). The fluorescence intensity was measured at 
excitation/emission of 488/605 nm to visualize the signal. The images were analysed 
using the Olympus Fluoview version 2.0 software. 
 
5.3.10  Vascular superoxide and peroxynitrite production 
Lucigenin-enhanced chemiluminescence method was used to estimate the vascular 
superoxide production as previously described (Lau et al., 2012a; Woodman & Malakul, 
2009). Briefly, aortic rings from each of the vehicle- and boldine-treated ring segments 
from the SD and STZ-induced diabetic rats was pre-incubated for 45 min at 37 °C in 2 
ml of Krebs-HEPES buffer (in mM: NaCl 99.0, NaHCO3 25, KCl 4.7, KH2PO4 1.0, 
MgSO4.7H2O 1.2, glucose 11.0, CaCl2.2H2O 2.5 and Na-HEPES 20.0) in the presence 
of diethylthiocarbamic acid (DETCA, 1 mM) to inactivate superoxide dismutase and β-
nicotinamide adenine dinucleotide phosphate (NADPH, 0.1 mM) as a substrate for 
NADPH oxidase. Diphenylene iodonium (DPI; 5 μM) was added for the positive 
control as an inhibitor of NADPH oxidase. Prior to measurement, a 96-well Optiplate 
was filled with 300 μl of Krebs-HEPES buffer containing lucigenin (5 μM) and 
NADPH (0.1 mM) per well and loaded into the Hidex plate CHAMELEON™ V 
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(Finland) in luminescent detection mode to measure the background photo emission 
over 20 min. At the end of measurement, the rings were dried for 48 h at 65 °C and 
weighed. The data were expressed as average counts per mg of vessel dry weight. 
 
Levels of ONOO
-
 production from aortas of different groups of rats were measured 
using the luminol-enhanced chemiluminescence method (CHAMELEON™ V, Hidex, 
Finland) as described (Lau et al., 2012a; Laursen et al., 2001). This method is similar to 
that used for superoxide detection with the exceptions that 1) luminol (100 μM) is used 
instead of lucigenin and 2) aortic rings were incubated in Krebs-HEPES buffer 
containing 1 mM DETCA and 0.1 mM NADPH in the presence and absence of uric 
acid (250 mM), a scavenger of ONOO
-
. 
 
5.3.11 Total nitrates/nitrites measurement 
The NO levels were measured by using Griess reagent kit (Sigma-Aldrich). Total nitrite 
and nitrate were determined as described by Ansari et al. (2007) with slight 
modification. Briefly, all the nitrates in plasma were converted into nitrites using 
aspergillus nitrate reductase (20 mU) in the presence of FAD (0.11 mM) and NADPH 
(100 µM). The incubation was carried out at 37 °C for 90 min in the dark. Equal volume 
of blood sample and 1X Griess reagent (Sigma, MO, USA) were mixed and the 
absorbance of the sample is read at 540 nm after 15 min. The reading was compared to 
the sodium nitrites standard curve. 
 
5.3.12 Western blot 
Aortas and cells were homogenized and lysed in ice-cold RIPA buffer (Santa Cruz 
Biotechnology, Santa Cruz, CA, USA). The lysates were then centrifuged at 20,000 g 
for 20 min and supernatants were collected for Western blotting. Protein concentrations 
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of the supernatant were determined by modified Lowry assay (Bio-Rad Laboratories, 
Hercules, CA, USA). For each sample, 10-30 μg of total tissue protein was separated in 
7.5-13% sodium dodecyl sulphate polyacrylamide gel and transferred onto 
nitrocellulose membranes. The non-specific binding was blocked with 5% non-fat milk 
or 3% bovine serum albumin in Tris-buffered saline containing 0.1% Tween-20 (TBS-T) 
for 1 h at room temperature with gentle shaking. After washing in TBS-T, the blots was 
incubated with either primary mouse monoclonal antibody of nitrotyrosine (1:500, 
Milipores), p47
phox
 (1:500, Santa Cruz), NOX-2 (1:1000, Abcam, UK), p67
phox
 (1:500, 
Santa Cruz) or Rac1 (1:1000, Abcam, UK) overnight at 4 °C. The next day, the 
membranes were washed three times for 5 min in TBS-T and incubated with respective 
secondary antibodies conjugated to horseradish peroxidase for 2 h at room temperature. 
The membranes were developed with Amersham
TM
 ECL plus Western Blotting 
detection system (Amersham, Bukinghamshire, UK). The membrane image was 
captured under the ChemiDoc-It® Imaging system (UVP, Cambridge, UK) and 
densitometric analysis was performed using Quantity One 1-D analysis software. The 
respective protein expression levels were normalized to housekeeping protein α-actin or 
GAPDH and data are expressed as a percentage of the values in the control group. 
 
5.3.13 Data analysis  
Results represent mean ± SEM from n rats. Concentration–relaxation curves were 
analysed by non-linear regression curve fitting using GraphPad Prism 4.0 software (San 
Diego, CA). Statistical significance were determined by one-way analysis of variance 
(ANOVA) followed by Bonferroni’s multiple comparison test for multiple value 
comparison. A value of P < 0.05 was considered statistically significant. 
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5.4. Results 
5.4.1 Boldine reduces high glucose-stimulated ROS formation 
Incubation with high glucose (30 mM, HG) for 48 h markedly increased the ROS 
formation in cultured rat aortic endothelial cells (RAEC) as reflected by the intensity of 
DCF fluorescence staining when compared with mannitol control (NG). Co-treatment 
with boldine (1 μM) or tempol (100 μM) reduced the high glucose-stimulated ROS rise 
(Figure 5.1A and 5.1B). Western blotting results revealed that treatment with either 
boldine or tempol inhibited the high glucose-stimulated up-regulation of NADPH 
subunits, NOX2 and p47
phox
 (Figure 5.1C and 5.1D) without affecting the expression of 
other subunits p67
phox
 and Rac1 (Appendix C) in RAEC.  
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Figure 5.1: Boldine reversed high glucose stimulated-ROS production in rat aortic 
endothelial cells (RAEC).  Confluent RAEC was cultured in the medium containing 
normal glucose (NG) or high glucose (HG, 30 mM), or co-treated  with either boldine (1 
μM) or tempol (100 μM) for 48 h. (A) Representative images showing the ROS 
elevation as measured by CM-H2DCF-DA fluorescence under various treatments. (B) 
Summarized value of results presented in A. The elevated expression of NOX2 (C) and 
p47
phox
 (D) was reduced by co-treatment of boldine or tempol. Results are mean ± SEM 
of 3 experiments using RAECs from different rats. NG: normal glucose (5 mM glucose 
+ 25 mM mannitol as osmotic control).  * P < 0.05, ** P < 0.01 compared with HG, # P 
< 0.01, ## P < 0.001 compared with NG. 
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5.4.2 Boldine attenuates high glucose-induced increases in nitrotyrosine formation 
High glucose stimulation (30 mM, 48 h) elevated formation of nitrotyrosine (an index 
for increased oxidative stress) in RAEC compared with normal glucose-treated 
endothelial cells; such increase was inhibited by treatment with boldine or tempol 
(Figure 5.2A and 5.2B). Western blotting showed that treatment with boldine and 
tempol reversed the high glucose-induced up-regulation of nitrotyrosine protein 
expression in RAEC (Figure 5.2C). 
 
5.4.3 Boldine increases NO bioavailability under high glucose stimulation 
The stimulated NO production in RAEC in response to ACh as revealed by the time-
dependent increase in the DAF fluorescence intensity was significantly lower after high 
glucose stimulation compared with normal glucose (Figure 5.3A and 5.3B). The effect 
of high glucose was reversed by co-treatment with boldine or tempol in RAEC (Figure 
5.3). 
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Figure 5.2: Boldine reduced high glucose-stimulated nitrotyrosine formation in RAEC.  
(A) Representative images and summarized results (B) showing the increased 
nitrotyrosine formation in high glucose-treated RAEC was reversed by the co-treatment 
with boldine.  (C) Western blot showing that the co-treatment with bodine normalized 
the increased nitrotyrosine formation in high glucose-treated RAEC. Results are mean ± 
SEM of 3 experiments using RAECs from different rats. * P < 0.05, ** P < 0.05 
compared with HG, # P < 0.05, ## P < 0.01 compared with NG. 
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Figure 5.3: Boldine reversed the diminished NO productions in high glucose-treated 
RAEC.  (A) Representative images showing the basal level (0 min) and ACh (10 μM)-
stimulated NO productions at 15 min in the four treatment groups. (B) Boldine restored 
the NO production in high glucose-treated RAEC. Results are mean ± SEM of 3 
experiments using RAEC from different rats. * P < 0.01 compared with NG, # P < 0.01 
compared with HG. 
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5.4.4 Body weight, plasma blood glucose and lipid profile 
At the end of treatment, body weight decreased significantly in STZ-induced diabetic 
rats compared to control rats. The plasma glucose level of diabetic rats was significantly 
greater than that of control rats. In diabetic rats, there was a slight decreased in blood 
glucose level after boldine treatment for 7 days (Table 5.1). STZ-treated rats exhibited a 
significantly higher plasma triglyceride level compared with control and this level was 
unaffected after 7-day treatment with boldine, while total plasma cholesterol, HDL and 
non-HDL levels were similar in all groups of rats (Table 5.2). 
 
 
Table 5.1: Effect of boldine treatment on mean body weight and blood glucose level 
 
Sprague Drawly rats and STZ-induced diabetic rats were treated with boldine (20 
mg/kg/daily, i.p.).  Results are mean ± SEM of 7-9 animals.  * P < 0.001 compared with 
control, # P < 0.05 compared with diabetes.   
 
 
 
 
 
Strain  Body weight (g) blood glucose 
(mmol/l) 
Before treatment  After treatment  
Control  231.1 ± 7.8  372.2 ± 13.9           5.1 ± 0.3  
Control + boldine  230.0 ± 7.1  376.7 ± 10.0           5.2 ± 0.2  
Diabetes  228.6 ± 6.9  157.1 ± 7.6           24.9 ± 0.4 *  
Diabetes + boldine  238.6 ± 6.9  179.4 ± 12.0           22.4 ± 0.5 #
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Table 5.2: Effect of boldine on lipid profiles  
  Control  Control + 
boldine     Diabetes  
Diabetes  + 
boldine 
Total cholesterol (mg/ml) 0.60 ± 0.09 0.58 ± 0.03 0.71 ± 0.04 0.72 ± 0.07 
Triglyceride (mg/ml) 0.92 ± 0.02 0.85 ± 0.07 1.94 ± 0.28 * 1.65 ± 0.32 * 
HDL (mg/ml) 0.06 ± 0.01 0.05 ± 0.01 0.10 ± 0.01 0.11 ± 0.03 
non-HDL (mg/ml) 0.47 ± 0.05 0.52 ± 0.03 0.61 ± 0.04 0.51 ± 0.07 
 
Effect of chronic boldine treatment (20 mg/kg/daily, i.p.) on levels of total cholesterol, 
triglyceride, HDL and non-HDL in vehicle- or boldine-treated Sprague Dawley (control) 
rats and STZ-induced diabetic rats. Results are mean ± SEM of 6 rats.  * P < 0.05 
compared with control. 
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5.4.5 Boldine reverses β-NADPH-induced impairment of endothelium-dependent 
relaxations in rat aortas 
Pre-incubation of aortic rings with β-NADPH attenuated the acetylcholine-induced 
endothelium-dependent relaxations. Boldine concentration-dependently (0.01- 1 µM) 
rescued the impaired relaxations (Figure 5.4A and 5.4B). The vascular oxidative stress 
induced by β-NADPH was confirmed with the addition of SOD, a superoxide scavenger 
in functional study. Pre-treatment with SOD prevented the β-NADPH-induced 
impairment of relaxations (Figure 5.4C). By contrast, endothelium-independent 
relaxations to SNP were comparable in all treatment groups and this suggests the 
relaxing sensitivity of vascular smooth muscle cells to NO remains unchanged (Figure 
5.4D). 
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Figure 5.4: Boldine reversed the β-NADPH-induced endothelial dysfunction in rat 
aortas. (A) Representative traces showing the β-NADPH-induced impairment of ACh-
evoked endothelium-dependent relaxation was improved by acute 30-min treatment 
with boldine which exhibited a concentration-dependent benefit (B). (C) SOD (50 U/ml) 
produced the same vascular protection as boldine (1 µM) in improving ACh-induced 
relaxations. (D) SNP-induced endothelium-independent relaxations were similar in all 
treatment groups. Results are mean ± SEM of experiments from 6 different rats.  
*P<0.01, **P<0.001 compared to β-NADPH, # P<0.001 compared with control.  
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5.4.6 Boldine improves endothelium-dependent relaxation in diabetic rat aortas 
Endothelium-dependent relaxations to ACh were significantly less in diabetic than in 
normal rat aortas (Figure 5.5A). Acute 30 min treatment with boldine (1 µM) restored 
the relaxations to the level seen in non-diabetic rat aortas (Figure 5.5A). Again neither 
STZ treatment nor boldine treatment modulated SNP-induced endothelium-independent 
relaxations (Figure 5.5D). The acute beneficial effect of boldine can be confirmed by 
chronic boldine treatment. STZ-induced diabetic rats were administered with boldine 
(20 mg/kg, i.p) for 7 days and aortas were then harvested for functional and biochemical 
assays. Chronic treatment with boldine significantly improved ACh-induced relaxations 
in diabetic rat aortas (Figure 5.5C) without affecting endothelium-independent 
relaxations to SNP (Appendix D). The improvement of endothelial function in boldine-
treated rats was accompanied by the restoration of the lost plasma nitrates/nitrites level 
in diabetic rats (Figure 5.5D).  
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Figure 5.5: Acute and chronic boldine treatment benefited endothelial function in STZ-
treated diabetic rats. Acute 30-min treatment of boldine (1 µM) restored ACh-induced 
endothelium-dependent relaxations (A) but not SNP-induced endothelium-independent 
relaxations (B) in diabetic rat aortas.  Chronic treatment with boldine improved ACh-
induced aortic relaxations (C) and the total plasma nitrates/nitrites (D) in STZ-induced 
diabetic rats. Results are mean ± SEM of experiments from 6-7 different rats. * P < 0.05, 
** P < 0.01, ** P < 0.001 compared with diabetes, # P < 0.01, ## P < 0.001 compared 
with control. 
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5.4.7 Boldine reduces in situ vascular superoxide formation and inhibits the 
elevated expression of p47
phox
 in diabetic rat aortas 
The intracellular superoxide formation measured by DHE fluorescence was higher in 
aortic rings from diabetic rats compared with control rats. Seven-day treatment of 
diabetic rats with boldine reduced the ROS accumulation in the vascular wall of diabetic 
rat aortas (Figure 5.6A and 5.6B). Boldine attenuated the increased level of the 
superoxide-generating p47
phox
 in the diabetic rat aorta (Figure 5.6C). 
 
5.4.8 Boldine reduces vascular superoxide and peroxynitrite in diabetic rat aortas 
Production of O2
−
 and ONOO
− 
in the diabetic rat aortas was significantly greater than 
controls (Figure 5.7). This increased superoxide production was abolished by DPI, a 
NADPH oxidase inhibitor. Uric acid, a direct ONOO
−
 scavenger reduced the ONOO
− 
level in all groups. Chronic treatment with boldine attenuated the excess aortic 
generation of O2
−
 and ONOO
−
 in the diabetic rat aortas (Figure 5.7).  
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Figure 5.6: Chronic boldine treatment reduced the oxidative stress level in diabetic rat 
aortas. The elevated DHE fluorescence intensity (A and B) and p47
phox
 level (C) in 
STZ-induced diabetic rat aortas were markedly reduced by administration with boldine. 
Results are mean ± SEM of 3-4 separate experiments.  * P < 0.05, ** P < 0.01 
compared with diabetes, # P < 0.001 compared with control. 
 
 
 
 
 
 
 
0
100
200
300
400
%
 p
4
7
p
h
o
x
/
 a
c
ti
n
0
500
1000
1500
2000
Control
Control + boldine
Diabetes
Diabetes + boldine
D
H
E
 i
n
te
n
s
it
y
#
*
p47phox
-actin
**
#
A B
C
Cont
Diabetes
Cont +
Boldine
Diabetes + 
boldine
200 µm
B 
  B 
B 
                                                                                                                        CHAPTER V 
85 
 
0
500
1000
1500
Control
Control + boldine
Diabetes
Diabetes + boldine
Diphenyleneiodonium
(DPI)
S
u
p
e
ro
x
id
e
 (
c
o
u
n
ts
/m
g
 o
f 
ti
s
s
u
e
)
#
*
0
200
400
600 Diabetes
Diabetes + boldine
Control
Control + boldine
Uric acid
P
e
ro
x
y
n
it
ri
te
(C
o
u
n
ts
/m
g
 o
f 
ti
s
s
u
e
)
#
*
A
B
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.7: Chronic treatment with boldine reduced the production of superoxide anion, 
O2
−
 (A) and peroxynitrite, ONOO
−
 (B) in aortic rings from STZ-induced diabetic rats. 
The NADPH oxidase inhibitor diphenyleneiodonium (DPI, 10 μM) and the ONOO− 
scavenger uric acid (250 mM) abolished the generation of O2
−
 and ONOO
−
, respectively. 
Results are mean ± SEM of 6 separate experiments.  * P < 0.001 compared with 
diabetes, # P < 0.001 compared with control. 
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5.5. Discussion  
The major findings of the present study include that (i) treatment with boldine 
effectively reduces high glucose-stimulated ROS and nitrotyrosine formation in rat 
aortic endothelial cells; (ii) acute treatment with boldine reverses the impaired 
endothelium-dependent aortic relaxations induced by β-NAPDH and in STZ-induced 
diabetic rats; and (iii) the in vitro effect of boldine is confirmed by in vivo treatment as 
chronic boldine administration improves endothelium-dependent relaxations in aortas 
from STZ-treated rats. This endothelial cell protection appears to correlate with the 
increase of NO bioavailability following boldine treatment. Collectively, the present 
study shows for the first time that boldine treatment attenuates the diabetes-associated 
oxidative stress and endothelial dysfunction through restoring the NO bioavailability. 
 
It has previously been shown in the STZ-induced diabetic rats, 8-week treatment with 
boldine decreased mitochondrial malondialdehyde and carbonyls in the liver, kidney 
and pancreas, and normalized the elevated Mn-SOD and GSH-peroxidase activity in 
mitochondria of the pancreas (Jang et al., 2000). We have also showed that chronic 
treatment with boldine restored endothelial function in hypertensive rats through the 
inhibition of NAD(P)H oxidase (Lau et al., 2012a).  However, there is little information 
concerning the vasoprotective effect of boldine in metabolic stress-related 
cardiovascular diseases, in particular endothelial dysfunction in diabetes. The present 
study provides novel evidence that boldine treatment is effective in reducing oxidative 
stress and thus restoring endothelial function in STZ-induced diabetic rats. 
 
We first examined the effect of boldine against high glucose-induced ROS over-
production in tissue culture. High glucose exposure markedly increases ROS generation 
in cultured rat aortic endothelial cells (RAEC) which is reversed by boldine at a low 
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concentration of 1 µM but high glucose did not affect the glutathione antioxidant system 
in RAEC (Appendix E). High glucose-stimulated ROS elevation is causally associated 
with increased expression of NADPH oxidase subunits including NOX2 and p47
phox
, 
which is also reduced by boldine. Superoxide anion reacts with NO to form ONOO
−
 and 
the latter further lowers bioavailability of NO (Maritim et al., 2003). We confirmed the 
contributory role of ONOO
−
 by detecting an elevated level of nitrotyrosine in high 
glucose-treated RAEC resulting from tyrosine nitration mediated by ONOO
−
 radicals. 
The increased O2
−
 may explain a low NO level in RAEC exposed to high glucose. Co-
treatment with boldine or tempol, equi-effectively reduces the elevated nitrotyrosine 
formation and increases the NO formation in endothelial cells. It is possible that ROS-
inhibiting effect of boldine or tempol is sufficient to restore the diminished NO 
production in high glucose-treated endothelial cells without affecting the eNOS 
expression (Appendix F), thus improving endothelial function.  
 
ROS derived from NAD(P)H oxidase plays a key role in vascular endothelial 
dysfunction in diabetes (Wong et al., 2010c).  In this study acute exposure to boldine 
effectively reversed the β-NAPDH-induced impairment of endothelium-dependent 
relaxations, thus indicating that the anti-oxidative (reduction of ROS) activity of boldine 
helps to preserve the bioavailability of NO. This finding is further supported by the 
improvement of endothelial function observed in isolated diabetic aortas that has been 
given acute and chronic treatment of boldine. The present study, for the first time, 
reveals the mechanism of vasoprotection of boldine in diabetic aortas is mediated 
through reducing ROS and increasing NO bioavailability. Further evidence is provided 
by the findings that 1)   elevated O2
-
 production in aortas of STZ-induced diabetic rats is 
reversed by chronic boldine treatment and 2) boldine suppressed the upregulated NOX2 
and p47
phox
 in the STZ-treated rat aortas and augmented the plasma levels of NO 
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metabolites. In contrast to the changes in endothelial function, the sensitivity of vascular 
smooth muscle to NO remained unaltered as SNP-induced endothelium-independent 
relaxation is comparable in all treatment groups (Figure 4D and 5B). The present results 
are in line with earlier reports of overexpression of p47
phox
 in high glucose-stimulated 
ROS generation in human coronary artery endothelial cells, vascular smooth muscle 
cells, and in diabetic rat arteries (Liu et al., 2007; Serizawa et al., 2011; Zheng et al., 
2010). Taken together, the present study demonstrates a vascular protective effect of 
boldine under hyperglycaemic conditions and the concomitant diabetic vasculopathy. 
 
Boldine has been shown to block α1-adrenoceptors in arteries from rats (Ivorra et al., 
1993a) and guinea pigs (Chulia et al., 1996). This α1-adrenoceptor blocking activity is 
unrelated to the endothelial cell protection conferred by boldine based on our 
observation that boldine at 1 µM used in the present study did not inhibit contraction 
triggered by phenylephrine, an α1-adrenoceptor agonist (Appendix G) and this study 
used another contractile agent, serotonin instead of phenylephrine. In addition, the 
vascular benefits of chronic treatment with boldine is unlikely to be associated with 
favourable modulation of metabolic parameters as boldine only slightly reduces plasma 
glucose levels (P < 0.05) without affecting lipid profile in diabetic rats.  
 
ROS has been implicated in the pathogenesis of β-cell destruction and liver injury in 
diabetes (Kakkar et al., 1998). Streptozotocin causes DNA fragmentation of pancreatic 
β-cell by stimulation of ROS generation in vitro and in vivo (Takasu et al., 1991). Jang 
et al (2000) reported that the plasma glucose lowering effect of boldine was associated 
with its cytoprotective action on pancreactic β-cell and the prevention of peroxidation 
products formation.  Boldine also attenuates the STZ-induced MDA formation, 
carbonyl formation and thio oxidation in the pancreas homogenates (Jang et al., 2000). 
                                                                                                                        CHAPTER V 
89 
 
The slight glucose lowering effect by boldine observed in this study may be related to 
its cytoprotective effect against the oxidative damage in pancreactic β-cell as reported 
by Jang et al (2000) although other contributing factors cannot be ruled out.  
 
5.6 Conclusion  
In summary, both in vitro (acute) and in vivo (chronic) treatments with boldine augment 
endothelial function through restoring the NO bioavailability in diabetic rats, thus 
indicating that boldine could be a potentially effective herb-derived ingredient in 
inhibiting oxidative stress and thus preserving endothelial function in hyperglycaemic 
or diabetic conditions.  
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CHAPTER VI 
BOLDINE IMPROVES ENDOTHELIAL FUNCTION IN DIABETIC DB/DB 
MICE THROUGH INHIBITION OF ANGIOTENSINII-MEDIATED BMP4 
OXIDATIVE STRESS CASCADE 
 
6.1 Abstract 
Boldine is a potent natural antioxidant present in the leaves and bark of Chilean boldo 
tree. The present study investigated the endothelial protective effect of boldine in 
arteries of db/db diabetic mice and in cultured mouse aortic endothelial cells receiving 
high glucose treatment. Vascular reactivity was studied in mouse aortas. Reactive 
oxygen species (ROS) production, angiotensin type 1 receptor (AT1R) localization and 
protein expression of oxidative stress markers in the vascular wall were evaluated by 
DHE fluorescence, lucigenin enhanced-chemiluminescence, immunohistochemistry and 
Western blot, respectively. The effect of boldine was also examined in high glucose (30 
mM)-treated primary mouse aortic endothelial cells. Both oral treatment (20 mg/ kg/day, 
7 days) and incubation in vitro with boldine (1 μM, 12 h) enhanced endothelium-
dependent aortic relaxations of db/db mice. Boldine reversed the impaired relaxations 
induced by high glucose or angiotensin II (Ang II) in non-diabetic mouse aortas while it 
reduced the ROS overproduction and increased the phosphorylation of eNOS in db/db 
mouse aortas. The elevated expression of oxidative stress markers such bone 
morphogenic protein 4 (BMP4), nitrotyrosine and AT1R was reduced in boldine-treated 
db/db mouse aortas. The Ang II-stimulated BMP4 expression was also inhibited by 
treatment with boldine, tempol, noggin and losartan.  Boldine inhibited high glucose-
stimulated ROS production and restored the lost phosphorylation of eNOS in mouse 
aortic endothelial cells. Boldine is effective to reduce oxidative stress and thus to 
improve endothelium-dependent relaxations in aortas of diabetic mice largely through 
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inhibiting ROS over-production associated with Ang II-mediated BMP4-dependent 
mechanisms.  
 
6.2 Introduction  
Type 2 diabetes, a common metabolic disorder, is characterized by hyperglycemia and 
hyperinsulinaemia which impair functions of both macro- and micro-circulation, and 
thus increases risks for developing hypertension and atherosclerosis (Senador et al., 
2009; Tranche et al., 2005). Excessive oxidative stress or increased production of 
reactive oxygen species (ROS) damage endothelial function as an early pathological 
event leading to cardiovascular diseases (Heitzer et al., 2001). For example, increased 
formation of NADPH oxidase-dependent superoxide anion has been observed in 
diabetic animals including db/db mice, diet-induced obese mice, Otsuka Long-Evans 
Tokishima Fatty (OLETF) rats, and Goto-Kakizaki (GK) rats (Gupte et al., 2010; Kim 
et al., 2002; Tian et al., 2011). Activation of angiotensin II (Ang II) type 1 receptor 
(AT1R) plays a critical role in mediating endothelial dysfunction through AT1R-
dependent NADPH-derived ROS over-production in arteries of db/db diabetic mice 
(Tian et al., 2011), while Ang II is a potent vasoconstrictor with  pro-inflammatory, 
mitogenic and profibrotic properties.  
 
Bone morphogenetic protein (BMP), a member of transforming growth factor-β 
superfamily, activates Smads as the immediate downstream molecules upon binding to 
BMP receptors (Chen et al., 2004). The isoforms of BMP family include BMP2, BMP4 
and BMP7 which are up-regulated in diabetes and act as pro-inflammatory regulators in 
blood vessels (Bostrom et al., 2011; Nett et al., 2006). BMP4 impairs endothelial 
function in mouse aortas either by increased ROS formation through NADPH oxidase 
or up-regulation of cyclooxygenase-2 (Miriyala et al., 2006; Wong et al., 2010a). An 
                                                                                                                        CHAPTER V 
92 
 
elevated expression of BMP4 and NAPDH oxidase in db/db mice suggests a positive 
involvement of this redox-sensitive pro-inflammatory mechanism in diabetes (San 
Martin et al., 2007). Therefore, natural products which improve endothelial function in 
diabetes by favorable modulation of redox-sensitive mechanisms could be potentially 
useful for treating diabetic vasculopathy. 
 
Boldine ((S)-2,9-dihydroxy-1,10-dimethoxy-aporphine)  is an aporphine alkaloid 
derived from benzylisoquinoline family and found to be the major alkaloid in the leaves 
and bark of Chilean boldo tree (Peumus boldus Molina) (O'Brien et al., 2006).  Boldine 
possesses a potent anti-oxidative property (Cassels et al., 1995). Although the 
pharmacological effects of boldine were reported a decade ago, it remains to be 
elucidated whether its antioxidant activity benefits vascular function in type 2 diabetic 
mouse model. Therefore, the present study investigated the hypothesis that in vivo and 
in vitro treatment with boldine ameliorates endothelial dysfunction in diabetic db/db 
mice by inhibiting Ang II-mediated BMP4-depenent oxidative stress cascade. 
 
6.3 Material and methods 
6.3.1 Chemicals 
Acetylcholine chloride (ACh), sodium nitroprusside (SNP), boldine, N
G
-nitro-L-
arginine methyl ester (L-NAME), phenylephrine, angiotension II (Ang II) were 
purchased from Sigma (St. Louis, MO, USA). Tempol was purchased from Tocris 
(Avonmouth, UK). Noggin and BMP4 were purchased from R&D System, Inc 
(Minneapolis, MN, USA). Losartan was purchased from Cayman (Ann Arbor, MI, 
USA). Noggin and BMP4 were dissolved in PBS plus 0.1% BSA and 4 mM HCl, 
respectively. Losartan was dissolved in DMSO. Boldine was dissolved in DMSO for in 
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vitro study or ethanol (20%) for oral feeding. Other drugs were dissolved in double 
distilled water. 
 
6.3.2 Animals and experimental protocol  
Male diabetic mice (C57BL/KSJ background) lacking the gene encoding for leptin 
receptor (db/db), heterozygote (db/m
+
) and non-diabetic C57 mice were purchased from 
the Laboratory Animal Service Center of Chinese University of Hong Kong (CUHK). 
The experimental procedures were approved by the CUHK Animal Experimentation 
Ethics Committee. Mice were maintained in a well-ventilated holding room at constant 
temperature of 24 ± 1°C and received normal chow and tap water ad libitum. The db/db 
mice (16-17 weeks old) were randomly assigned to control (vehicle), boldine, and 
tempol treatment group, and they were treated daily with vehicle (20% ethanol, 0.8 ml/ 
kg), or boldine (20 mg/
 
kg/ day) or tempol (20 mg/
 
kg/
 
day) by oral administration for 7 
days. At the end of the treatment period, mice were sacrificed by CO2 inhalation. 
  
6.3.3 Artery preparation 
The thoracic aorta was isolated, cleaned of surrounding connective tissues, and cut into 
several ring segments, 2 mm each in length. Rings were suspended in a Multi Wire 
Myograph System (Danish Myo Technology, Aarhus, Denmark) and bathed in 
oxygenated Krebs solution containing (in mM) NaCl 119, NaHCO3 25, KCl 4.7, 
KH2PO4 1.2, MgSO4.7H2O 1.2, glucose 11.7, and CaCl2.2H2O 2.5. Some arteries were 
snap-frozen in liquid nitrogen and stored in -80 °C for later processing. All rings were 
maintained at 37 °C, stretched to an optimal baseline tension of 3 mN, and continuously 
oxygenated by 95% O2 and 5% CO2. The changes of isometric tension were recorded by 
a PowerLab LabChart 6.0 recording system (AD Instruments, Australia).  
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6.3.4 Experimental protocol  
After 30 min equilibration, rings were first contracted by 60 mM KCl and washed in 
Krebs solution three times before phenylephrine (1 μM) was added to induce a stable 
contraction. Concentration-response curves for both endothelium-dependent relaxations 
in response to acetylcholine (ACh, 3 nM to 10 μM) and endothelium-independent 
relaxations to sodium nitroprusside (SNP, 1 nM to 10 μM) were obtained.  
 
6.3.5 Detection of ROS formation in en face endothelium and cryostat section of 
mouse aortas  
The oxidative stress level in en face endothelium and cryostat section of mouse aortas 
was assessed by confocal microscopy using dihydroethidium (DHE) dye. The aortic 
segments and cryostat sections (5 µm) of mouse aortas were pre-incubated in DHE (5 
µM, invitrogen, CA, USA) for 15 min in normal physiological saline solution (NPSS: 
NaCl 140, KCl 5, CaCl2 1, MgCl2 1, glucose 10 and HEPES 5 mM) (Tian et al., 2012a). 
At the end of incubation period, the aortic DHE dye was washed away and the 
fluorescence intensity at one optical section of the rings was visualized using Olympus 
FV1000 laser scanning confocal system (Olympus, America Inc., Melville, NY, USA). 
The fluorescence intensity was measured at 515 nm excitation and 585 nm emission and 
the images were analyzed using Olympus Fluoview software (version 2.0). 
 
6.3.6 Detection of vascular superoxide formation 
The amount of superoxide anion formation was determined using lucigenin-enhanced 
chemiluminescence method (Lau et al., 2013). Briefly, isolated mouse aortic rings were 
pre-incubated for 45 min at 37 °C in 2 ml of Krebs–HEPES buffer (in mM: NaCl 99.0, 
NaHCO3 25, KCl 4.7, KH2PO4 1.0, MgSO4.7H2O 1.2, glucose 11.0, CaCl2.2H2O 2.5 
and Na-HEPES 20.0) in the presence of diethylthiocarbamic acid (DETCA, 1 mM) to 
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inactivate superoxide dismutase (SOD) and β-nicotinamide adenine dinucleotide 
phosphate as NADPH oxidase substrate (0.1 mM). The rings were then transferred into 
vials containing 300 ul of Krebs-HEPES buffer containing 10 μM lucigenin. Repeated 
measurements were made over 10 min in 1 min intervals using luminometer (GloMax® 
20/20 Luminometer, WI, USA). The data were expressed as average counts per mg of 
tissue dry weight. 
 
6.3.7 Detection of AT1R by immunohistochemical staining 
The localization of AT1R in mouse aortas was determined by immunohistochemistry 
(Wong et al., 2010a). Briefly, aortic rings were fixed in 4% paraformaldehyde at 4 °C 
overnight and preceded to dehydration and embedding in paraffin on the following day. 
The paraffin block was cut into 5-µm thick sections on microtome (Leica Microsystems, 
Germany), followed by re-hydration. Sections were then treated with 1.4% H2O2 in 
absolute methanol for 30 min at room temperature to block the activity of endogenous 
peroxidase. To avoid false negative staining, sections were boiled in 0.01 M sodium 
citrate buffer (pH 6) for 15 min to unmask antigenic sites in the specimens. After 
washes in PBS, sections were blocked with 5% donkey serum (Jackson 
Immunoresearch, PA, USA) for 1 h and incubated with primary mouse monoclonal 
antibody AT1R (1: 50, Abcam, Cambridge, UK) overnight in a humidified chamber at 
4 °C. At the end of incubation period, sections were incubated with biotin-SP 
conjugated goat anti-mouse secondary antibodies (1:200, Jackson Immunoresearch, PA, 
USA) for 1 h at room temperature and then for 30 min with streptavidin-HRP conjugate 
(1:200, Zymed laboratory, CA, USA). Sections were washed in PBS for three times and 
colors were developed using 3,3’-diamonobenzidine (DAB) peroxidase substrate kit 
(Vector laboratory, CA, USA). The nuclei were counterstained with haematoxylin and 
the section without primary antibody served as negative control. Images were captured 
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using Leica DMRBE microscope coupled to SPOT-RT cooled CCD color digital 
camera and SPOT Advanced software (Version 3.5.5, Diagnostic Instruments, MI, 
USA). 
 
6.3.8 Organ culture of isolated aortas 
The isolated aortic rings were cultured in Dulbeco’s Modified Eagle’s Media (DMEM, 
Gibco, Gaithersberg, MD) supplemented with 10% fetal bovine serum (FBS, Gibco), 
100 U/ml penicillin and 100 μg/ml streptomycin. Aortas from db/db mice were 
incubated for 12 h in the presence or absence of boldine (1 μM in 0.001% DMSO), 
tempol (SOD mimetic, 100 μM), noggin (BMP4 antagonist, 100 ng/ml) or losartan 
(AT1R blocker, 3 μM).  Aortic rings from C57 mice were incubated in normal glucose 
(NG, 5 mM glucose and 25 mM mannitol as osmotic control of high glucose), high 
glucose (30 mM) and co-treatment with either boldine (1 μM) or tempol (100 μM) for 
36 h in a 5% CO2 incubator at 37 °C. In another set of experiments, rings were treated 
with Ang II (0.5 µM) for 24 h and thereafter transferred to wire myographs for 
functional examinations.  
 
6.3.9 Primary culture of mouse aortic endothelial cells 
Primary mouse aortic endothelial cells (MAECs) were isolated from two male mice 
(C57BL/6J at age of 5-6 weeks) (Tian et al., 2012a). In brief, the aorta was isolated 
from C57 mice after single intraperitoneal injection of pentobarbital sodium (40 mg/kg) 
and perfusion of heparin (100 U/ml) to the circulation from the left ventricle. The aortas 
were dissected in sterile ice-cold PBS to remove adipose and connective tissues, 
incubated for 10 min in collagenase type 1A (Sigma, MO, USA) solution at 37 °C with 
gentle shaking. Detached endothelial cells were centrifuged at 1500 rpm for 10 min and 
the cell pellets were re-suspended and cultured in endothelial cell growth medium 
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(EGM, Gibco, invitrogen, CA, USA) containing 20% FBS, 100 U/ml penicillin and 100 
μg/ml streptomycin in addition of endothelial cell growth supplement (50 µg/ml, BD 
Transduction Laboratory, CA, USA). The cells were kept in a humidified atmosphere 
containing 5% CO2 at 37 °C for 45 min and culture medium was then replaced and 
allowed to grow into confluence. Cells from passages between 1 and 3 were used for the 
present study. The endothelial cells were verified by positive staining to PECAM-1 
(Santa Cruz, CA, USA) and negative staining to smooth muscle marker, b-actin (Dako, 
Denmark). 
 
6.3.10 Measurement of intracellular ROS formation in MAECs 
The intracellular ROS production in MAECs was measured by a fluorogenic probe, 
CM-H2DCFDA and the fluorimetric signal was captured on an Olympus FV1000 laser 
scanning confocal system (Olympus, America Inc., Melville, NY, USA). Briefly, the 
confluent MAECs were seeded on circular cover slip and incubated in a low serum 
medium (EGM with 2% FBS) for 4 h. The cells were then exposed to high glucose (30 
mM) for 36 h with or without co-treatment with boldine (1 μM) or tempol (100 μM). At 
the end of treatment,  cells were washed twice in NPSS and preloaded with CM-
H2DCFDA (1 μM) for 20 min at 37 °C before the fluorescence signal was measured at 
488 nm excitation and 520 nm emission.  
 
6.3.10 Western blotting 
Aortas and MAECs were homogenized in ice-cold 1X RIPA buffer containing leupeptin 
1 μg/ml, aprotonin 5 μg/ml, PMSF 100 μg/ml, sodium orthovanadate 1 mM, EGTA 1 
mM, EDTA 1 mM, NaF 1 mM, and β-glycerolphosphate 2 mg/ml. The lysates were 
centrifuged at 20,000 g for 20 min and supernatant was collected for Western blotting. 
Protein concentrations of the supernatant were determined by modified Lowry assay 
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(Bio-Rad Laboratories, Hercules, CA, USA).  A 15 μg of protein loaded in each lane 
was separated on 7.5% or 10% sodium dodecyl sulphate (SDS)-polyacrylamide gel and 
then transferred to an immobilon-P polyvinylidene difluoride membrane (Millipore, 
Billerica, MA, USA) at 100 V. The blots were blocked for non-specific binding with 2% 
bovine serum albumin (BSA) or 5% non-fat milk in Tris-buffered saline containing 0.1 % 
Tween 20 (TBS) for 1 h at room temperature with gentle shaking. After it was rinsed in 
TBS-T, the blots were incubated with either primary polyclonal anti- eNOS at Ser1177 
(p-eNOS
Ser1177
) (1:500, Cell Signaling Technology, MA, USA), monoclonal anti-eNOS 
(1:500, BD Transduction laboratory), anti-nitrotyrosine (1:1000, Milipore, MA, USA ), 
anti-AT1R (1:1000, Abcam, Cambridge, UK), anti-BMP4 (1:500, Sigma, MO, USA). 
After overnight incubation at 4 °C, the membranes were washed three times and 
incubated with respective secondary antibodies conjugated to horseradish peroxidase for 
2 h at room temperature. The membranes were developed with Amersham
TM
 ECL plus 
Western blotting detection system (Amersham, Bukinghamshire, UK) and images were 
captured under ChemiDoc-It® Imaging system (UVP, Cambridge, UK). The 
densitometric analysis was performed using VisionWorks®LS analysis software and the 
respective protein expression levels were normalized to housekeeping protein β-actin or 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH). 
 
6.3.11 Statistical analysis 
Results represent mean ± standard error of mean (SEM) for number (n) of mice. 
Concentration-response curves were fitted to a sigmoidal curve using non-linear 
regression with the aid of the statistical software GraphPad Prism version 4, USA. The 
observed responses were analyzed for statistical significance using Student’s t-test for 
unpaired observations and the one-way analysis of variance (ANOVA) followed by 
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Bonferroni’s multiple comparison test for multiple value comparison (Prism 5.0, 
GraphPad Software, USA). A value of P < 0.05 was taken statistically significant. 
 
6.4 Results 
6.4.1 Boldine improves endothelial function in diabetic db/db mice 
Figure 1 shows the impaired endothelium-dependent relaxations to ACh (Figure 6.1A) 
but not endothelium-independent relaxations to SNP (Figure 6.1B) in aortic rings from 
db/db mice compared with those from db/m
+
 mice. One-week oral administration of 
boldine (20 mg
/
kg/day) or tempol (20 mg/kg/day) to db/db mice rescued the impaired 
ACh-induced relaxations (Figure 6.1A & Table 6.1) without affecting SNP-induced 
responses in aortic rings (Figure 6.1B). Such treatment did not modulate plasma lipid 
profile or glucose levels (Appendix H & I). In addition, treatment with either boldine or 
tempol restored the lost phosphorylation of eNOS at Ser1177 in db/db mouse aortas 
(Figure 6.1C). Likewise, 12 h in vitro treatment with boldine (1 μM) or tempol (100 μM) 
also rescued the impaired ACh-induced relaxations in db/db mouse aortas (Figure 6.2A 
& B) without affecting SNP-induced relaxations (Figure 6.2D). The impaired 
relaxations were also reversed by treatment with AT1R antagonist losartan (3 μM) and 
bone morphogenic protein-4 (BMP4) antagonist, noggin (100 ng/ml) (Figure 6.2C).  
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Table 6.1: The agonist sensitivity (pEC50) and percentage of maximum response (Rmax) 
of ACh-induced endothelium-dependent relaxations in aortic rings isolated from db/m
+
 
and db/db 
 
 
 
 
 
 
 
Results are means ± SEM of 6 separate experiments.  # P< 0.01 compared to db/m
+
 
* P<0.01 compared to db/db 
 
 
 
 
 ACh 
Group pEC50 (log M)  Rmax (%) 
db/m+          6.60 ± 0.06         82.42 ± 2.03 
db/db 4.35 ± 0.47 # 29.00 ± 6.25 # 
db/db + boldine 6.28 ± 0.12 * 71.00 ± 7.65 * 
db/db + tempol 6.81 ± 0.15 * 70.00 ± 8.66 * 
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Figure 6.1: The ACh-induced endothelium-dependent (A) and SNP-induced 
endothelium-independent relaxations (B) in aortic rings from db/db mice orally treated 
with vehicle (20% EtOH), or boldine (20 mg/kg/day), or tempol (20 mg/kg/day). (C) 
Chronic boldine treatment increased the level of eNOS phosphorylation at Ser1177 in 
aortas of db/db mice. Results are shown as mean ± SEM of 6 separate experiments. # P 
<0.05 compared to db/m+ mice; * P <0.05 compared to db/db mice. 
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Figure 6.2: In vitro exposure to boldine (1 μM) or tempol (100 μM) for 12 h prevents 
impaired ACh-induced endothelium-dependent relaxations in db/db mouse aortas (A, B); 
whilst, SNP-induced endothelium-independent relaxations were unaffected in all group 
(D). Treatment (12 h) with BMP4 antagonist noggin (100 ng/ml) and AT1R antagonist 
losartan (3 μM) improved endothelial function in aortas of db/db mice (C). Results are 
means ± SEM of 6 separate experiments. # P <0.05 compared to db/m+ mice; * P <0.05 
compared to db/db mice. 
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6.4.2 Boldine reduces vascular oxidative stress markers in db/db mice 
One-week treatment with boldine or tempol normalized the elevated ROS accumulation 
in en face endothelium (Figure 6.3A), across the vascular wall (Figure 6.3B), and 
superoxide anion levels (Fig. 6.3C) in aortas from db/db mice as reflected by DHE 
fluorescence dye and using lucigenin enhanced-chemiluminescence method.  The 
Western blot results show that the elevated protein expression of BMP4 (Figure 6.4A) 
and nitrotyrosine (another oxidative stress index, Figure 6.4B) in db/db mouse aortas 
was reversed by chronic treatment with boldine or tempol. 
 
6.4.3 Boldine reduces the expression of AT1R in db/db mouse aortas 
Immunohistochemistry staining showed the presence of AT1R in both endothelial cells 
and smooth muscle cells in mouse aortas and chronic treatment with boldine or tempol 
reduced the expression of AT1R in the aortas in db/db mice (Figure 6.5A). Such effects 
were confirmed by the Western blot data (Figure 6.5B).  
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                        CHAPTER V 
104 
 
 
 
 
 
Figure 6.3: Chronic boldine treatment reversed the elevated ROS in en face endothelium 
(A) and cryostat section of db/db mouse aortas (B) as indicated by changes of the DHE 
fluorescence intensity and inhibited the increased generation of superoxide anion in 
these aortas (C) as detected using lucigenin-enhanced chemiluminescence method. 
Results are means ± SEM of 4-6 separate experiments. # P <0.05 compared with db/m
+
 
mice; * P <0.05 compared with db/db mice. 
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Figure 6.4: Western blotting showing the up-regulation for expressions of BMP4 (A) 
and nitrotyrosine (B) in aortas from db/db mice with and without receiving one-week 
treatment with boldine or tempol. Results are means ± SEM of 4 separate experiments. 
# P <0.05 compared with db/m+ mice; * P <0.05 compared with db/db mice. 
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Figure 6.5: One-week treatment with boldine or tempol reduced the AT1R expression in 
db/db mouse aortas as detected by immunohistochemistry (A) and Western blotting (B). 
Arrows indicate the endothelial layer of the artery. Results are shown as mean ± SEM of 
3-4 separate experiments.  # P <0.05 compared with db/m
+
 mice; * P <0.05 compared 
with db/db mice. 
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6.4.4 Boldine protects against Ang II-induced BMP4-dependent endothelial 
dysfunction 
Ang II (500 nM) attenuated the ACh-induced relaxations in aortas from non-diabetic 
C57 mice (Figure 6.6A & B) and this impairment was reversed by co-treatment with 
BMP4 inhibitor noggin or AT1R antagonist losartan (Figure 6.6A). Ang II elevated the 
expression of BMP4 in cultured mouse aortas and this effect was reversed by noggin or 
losartan (Figure 6.6C). Like noggin or losartan, both boldine and tempol also reversed 
the impairment of ACh-induced relaxations (Figure 6.6B) and up-regulation of BMP4 
expression in Ang II-treated aortas from non-diabetic mice (Figure 6.6D).   
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Figure 6.5: Ang II-induced impairment of ACh-induced relaxations was reversed by in 
vitro treatment with boldine (1 µM, A), tempol (100 µM, A), noggin (100 ng/ml, A) and 
losartan (3 µM, A) in aortas from non-diabetic mice. These four inhibitors normalized 
Ang II-induced increase in BMP4 expression (C & D). Results are means ± SEM of 4-6 
separate experiments. #P <0.05 compared with control; *P <0.05 compared with Ang II. 
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6.4.5 Boldine reverses high glucose-induced endothelial dysfunction in mouse 
aortas 
Exposure to high glucose (36 h) attenuated ACh-induced relaxations and this effect was 
reversed by co-treatment with boldine (1 μM) or tempol (100 μM) (Figure 6.7A & B).  
Treatment with high glucose for 36 h elevated the ROS production in MAECs as 
indicated by changes of the DCF-DA fluorescence intensity, while ROS elevation was 
prevented by pre-treatment (8 h, Appendix J) and co-treatment (Figure 6.7C & D) with 
boldine or tempol.  In addition, high glucose-induced reduction in eNOS 
phosphorylation in MAECs was reversed by co-treatment with boldine or tempol 
(Figure 7E). 
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Figure 6.6: In vitro treatment with boldine or tempol reversed high glucose-induced 
impairment of ACh-induced relaxations in non-diabetic mouse aortas (A & B) and 
normalized the elevated ROS production in high glucose (HG)-treated MAECs (C & D). 
(E) Boldine and tempol increased the eNOS phosphorylation in HG-treated MAECs.  
NG: normal glucose (5 mM glucose and 25 mM mannitol as osmotic control of HG). 
Results are means ± SEM of 4-6 separate experiments. # P <0.05 compared with NG; 
*P < 0.05 compared with HG. 
C                                D
E
NG HG HG
B
HG
T
0.0
0.5
1.0
1.5
2.0
C
M
-H
2D
C
F
-D
A
flu
or
es
ce
nc
e
(f
ol
d 
of
 c
on
tr
ol
)
*
#
*
100 µM
NG  
HG
Boldine + HG
Tempol + HG
high glucose c57 #2 2 day
N (
mN
)
3
4
5
6
7
8
1:33:00 1:34:00 1:35:00 1:36:00 1:37:00 1:38:00 1:39:00 1:40:00 1:41:00 1:42:00 1:43:00 1:44:00 1:45:00 1:46:00 1:47:00 1:48:00 1:49:00 1:50:00 1:51:00 1:52:00 1:53:00 1:54:00
6/7/2011 16:23:44.806
•
• •
•
•
•
•
•
•
NG
high glucose  c57 190811
HG
 (
m
N)
2
4
6
8
3:00 4:00 5:00 6:00 7:00 8:00 9:00 10:00 11:00 12:00 13:00 14:00 15:00 16:00 17:00 18:00 19:00 20:00 21:00 22:00 23:00 24:00 25:00 26:00
19/8/2011 13:22:55.363
• •
••
•
•
•
•
•
HG
high glucose  c57 290711
H
G
B
 (
m
N
)
2
4
6
8
10
5:00 6:00 7:00 8:00 9:00 10:00 11:00 12:00 13:00 14:00 15:00 16:00 17:00 18:00 19:00 20:00 21:00 22:00 23:00
29/7/2011 10:35:27.292
•
•
•
•
•
•
•
•
•
Boldine + 
HG
high glucose  c57 290711
H
G
T 
(m
N
)
2
4
6
8
10
12
42:00 43:00 44:00 45:00 46:00 47:00 48:00 49:00 50:00 51:00 52:00 53:00 54:00 55:00 56:00 57:00 58:00 59:00 1:00:00 1:01:00
29/7/2011 11:12:27.292
•
•
••
•
•
•••
Phe
Tempol + 
HG
4 min
2 
m
N
A                                 B
Acetylcholine (µM) 
-9 -8 -7 -6 -5
0
50
100
NG
HG
Tempol + HG
Boldine + HG
ACh (log M)
R
el
ax
at
io
n 
(%
)
*
#
0.01
0.1
1
10
peNOSSer1176
eNOS
GAPDH
High                   Low
ROS
#
**
*
NG HG HG
B
HG
T
0.0
0.5
1.0
1.5
p-
eN
O
S
S
er
S
11
76
/e
N
O
S
(c
om
pa
re
d 
to
 N
G
 c
on
tr
ol
)
B
B B 
C
B B 
E
B 
                                                                                                                        CHAPTER V 
111 
 
6.5 Discussions  
The present study provide new experimental evidence showing that in vivo treatment 
with boldine can effectively restore the impaired endothelium-dependent relaxations in 
aortas of db/db mice and reduces oxidative stress as signified by marked reduction in 
the expression of BMP4, nitrotyrosine and AT1R in diabetic mouse arteries. The renin-
angiotensin system (RAS) and associated oxidative stress play a crucial role in 
maintaining endothelial dysfunction in diabetic mice (Wong et al., 2010b) while BMP4 
is a novel important mediator of endothelial dysfunction in hypertension (Tian et al., 
2012b). To further elucidate the possible inhibitory effect of boldine on Ang II-
mediated vascular dysfunction, Ang II was used to trigger ROS generation and thus 
reduce the bioavailability of NO in the vascular wall. As expected, in vitro Ang II 
treatment impairs endothelium-dependent relaxations accompanied by the elevated 
BMP4 expression in aortas from non-diabetic mice. Co-treatment with boldine reverses 
the harmful effects of Ang II on relaxations and BMP up-regulation. It appears that 
boldine reduces Ang II-induced BMP expression mainly through limiting ROS 
generation in the inflamed arteries as the known ROS inhibitor tempol produces the 
same benefits as boldine. In addition, reducing the AT1R expression and associated 
ROS over-production also play a positive role in boldine-induced improvement of 
endothelial function in diabetic db/db mice. 
 
Boldine was described before to ameliorate the development of diabetes in 
streptozotocin-induced rats by inhibiting oxidative stress-associated tissue damage and 
restoring the antioxidant enzyme activities (Jang et al., 2000a). We have recently 
described that treatment with boldine reverses endothelial dysfunction in hypertensive 
rats through suppression of NADPH oxidase-mediated ROS over-production (Lau et al., 
2012a) and protects endothelial function in hyperglycaemia-induced oxidative stress 
                                                                                                                        CHAPTER V 
112 
 
through inhibiting NADPH oxidase expression (Lau et al., 2013). In addition, boldine 
was reported to reduce the carrageenan-induced guinea pig paw oedema probably 
through inhibiting the biosynthesis of pro-inflammatory prostaglandins (Backhouse et 
al., 1994). However, the effect of boldine on endothelial dysfunction and vascular 
inflammatory response in type 2 diabetes remains unclear. The present study reports 
novel findings on the endothelial cell protective effect of boldine involving inhibition of 
Ang II-mediated BMP4 up-regulation and ROS overproduction induced by 
hyperglycemia.  
 
The RAS and associated NADPH oxidase-derived ROS mediate endothelial dysfunction 
in the mouse model of type 2 diabetes through decreasing NO bioavailability in the 
vascular wall (Wong et al., 2010b). The present study shows that the impaired 
endothelium-dependent relaxations in db/db mouse aortas or in high glucose-treated 
mouse aortas were reversed by both in vivo and in vitro treatment with boldine or 
tempol. This improved relaxations correlate with the restored level of eNOS 
phosphorylation. Additional support comes from experiments on cultured mouse 
endothelial cells in which the high glucose-induced reduction in the level of p-eNOS 
was reversed by boldine or tempol.  
 
Bone morphogenetic protein 4, an important matrix cytokine is present in 
atherosclerotic plaques and it stimulates the expression of adhesion molecules and 
induces endothelial dysfunction through NADPH oxidase-dependent pathway (San 
Martin et al., 2007). Up-regulation of BMP4 in db/db mouse aortas may involve ROS-
dependent vascular inflammation (San Martin et al., 2007). Likewise, the present results 
demonstrate that endothelial dysfunction in diabetic mice was accompanied by 
augmented oxidative/nitrosative stress and BMP4 up-regulation. Treatment with boldine 
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rescued rescued the impaired endothelial function in db/db mice and inhibited both ROS 
over-production and BMP4 up-regulation. The present study thus reveals that the 
increased expression and activity of the RAS is likely to up-regulate the expression of 
BMP4 and the latter is associated ROS over-generation, leading to the impaired 
endothelial function in diabetes, while boldine protects endothelial cell function through 
inhibiting AT1R-BMP4-ROS axis. Similarly, boldine reversed the Ang II-induced 
endothelial dysfunction in vitro and reduced the Ang II-induced BMP4 protein 
expression. Both actions of Ang II were also alleviated in the presence of losartan, 
AT1R blocker and noggin, an inhibitor of BMP4, suggesting that the impairment of 
endothelial dysfunction in db/db mouse aorta may be attributed to the Ang II-induced 
BMP4 oxidative stress cascade. A recent study also reported that BMP4 plays a 
pathophysiological role in Ang II-induced cardiomycyte hypertrophy where BMP4 
expression was increased by Ang II treatment in cultured cardiac fibroblasts (Sun et al., 
2013). However, from the present findings, participation of other BMPs such as BMP2, 
BMP6 and BMP7 in vascular oxidative stress and vascular inflammation in animal 
model of diabetes mellitus cannot be entirely ruled out. 
 
6.6 Conclusion 
Taken together, the present study provides novel evidence demonstrating that boldine is 
effective in inhibiting the AT1R-mediated cellular signaling cascade and ameliorating 
endothelial dysfunction in diabetic mice. Our findings further suggest a therapeutic 
potential of boldine-containing medicinal herbs in alleviating diabetic vasculopathy. 
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CHAPTER VII 
CONCLUSION 
 
Oxidative stress associated with the imbalance of excessive generations of free radicals 
and low levels of antioxidants have received considerable attention in recent years. 
Increasing evidence indicates that developments of chronic cardiovascular related 
diseases are strongly correlated with elevated oxidative stress. Oxidative stress is caused 
by overproduction of ROS such as O2
−
  and ONOO
−  
and it is an important contributor to 
the development of endothelial dysfunctions in chronic diseases such as hypertension, 
diabetes mellitus and atherosclerosis. The pathophysiology of endothelial dysfunction is 
complex and however, is always associated with decreased NO bioavailability. The 
protective role of antioxidants in oxidative stress-related diseases is well documented 
and forms an important complimentary therapy to conventional treatments. Although 
many antioxidants such as vitamin E, ascorbic acid, and calcitriol have been given to 
animals and in clinical studies to prevent the development of cardiovascular 
complications, numerous “natural” antioxidants derived from plants remain unexplored 
scientifically.  
 
In the present study, we further examine plant derived antioxidants as potential 
endothelial protective agents against the damaging effects of free radicals in oxidative 
stress related diseases such as hypertension and diabetes mellitus. Preliminary results 
showed that the methanolic extracts of Phoebe grandis (MPG) a local plant, in which 
boldine is a major compound exhibited potent antioxidant activity in several antioxidant 
assays including DPPH, ORAC and cell-free xanthine/xanthine oxidase superoxide 
generation system. In the isolated aorta of Sprague Dawley rats, MPG was further 
demonstrated to significantly reverse the endothelial dysfunction induced by the 
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oxidative stress inducer β-NADH and restoring the endothelium-dependent relaxations 
to ACh as in the vehicle-treated vessels. In addition, MPG inhibited the generation of 
vascular superoxides induced by β-NADH in the isolated rat aorta. This endothelial 
protective effect of MPG served as an important basis for further exploration of ‘natural’ 
antioxidants derived from Malaysian plants and their potential medicinal uses.  
 
Impaired endothelium-dependent relaxation and decreased NO bioavailability are 
commonly reported in animal models of hypertension and diabetes mellitus (both type 1 
and type 2). In the subsequent study, the endothelial protective effect of boldine was 
investigated in a hypertensive rat model. Endothelial dysfunction in the SHRs is 
associated with increased SBP and NADPH oxidase mediated oxidative stress. 
Increased NADPH-induced O2− production scavenges endothelium-derived NO, leading 
to reduced NO levels as well as increased formation of ONOO− which further 
diminishes the protective role of NO in the regulation of the vasculature. Repeated 
treatment of the SHRs with boldine for 7 days attenuated the elevated SBP and 
improved the endothelium dependent relaxations to ACh in the isolated aorta from these 
rats. This provided further support that the endothelial protective effects of boldine in 
hypertensive rats is at least in part due to inhibition of NADPH-mediated superoxide 
production. Protein expression studies denote that the inhibitory effect of boldine on the 
NADPH oxidase is associated with down-regulation of the membrane-bound regulatory 
cytosolic protein subunit, p47phox. This novel finding of the cellular action of boldine 
provide further support to the antioxidant actions and therapeutic potential of the 
alkaloid in the regulation of vascular tone and the maintenance of vascular patency to 
preserve cardiovascular health. 
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Similarly, boldine exhibited potent antioxidant effects in both in vitro and animal 
models of type 1 and type 2 diabetes. As in hypertension, excessive generations of ROS 
interfere with NO signalling and play a critical pathological role in the development of 
the vascular complications associated with diabetes. In hyperglycaemia, glucose 
autoxidation increases production of free radicals leading to overproduction of ROS and 
subsequent inactivation of NO.  
 
In both STZ-induced diabetic rat (type 1 diabetes) and db/db mice (type 2 diabetes), 
endothelial dysfunctions were markedly observed by the impaired endothelium-
dependent relaxations to ACh in isolated rat or mouse aorta. Acute (30 min pre-
treatment) and repeated treatment (7 days) of boldine significantly reversed the 
impaired endothelial function in aorta of both diabetic animals. As in hypertensive 
vessels, the endothelial protective actions of boldine strongly attributed to decreasing 
ROS formation and enhancing NO bioavailability via improving activity of eNOS in the 
aortic wall of the diabetic animals. Incubation of rat and mouse aortic endothelial cells 
grown in high glucose medium with boldine, decreased the generation of O2− in these 
cells and thus protecting NO degradation. In the type 1 diabetic rats, treatment with 
boldine normalized the overproduction of ROS and this correlated with the 
downregulation of the NADPH oxidase subunits NOX2 and p47phox. Repeated treatment 
with boldine in the db/db mouse decreased protein expression of AT1R and BMP4 in 
the vascular wall. This finding suggests that in the type 2 diabetic mice, boldine may 
additionally, reduced the generation of superoxide anions by inhibiting the AT1R-
BMP4-ROS axis and increasing eNOS phosphorylation. 
 
Taken together, it appears that boldine may exert positive effects on the endothelium via 
several mechanisms including mainly by protecting NO from degradation via inhibiting 
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the excessive production and scavenging of superoxides, and additionally by increasing 
NO bioavailability by promoting eNOS phosphorylation. The present results further 
support the potential use of boldine as a naturally effective antioxidant with protective 
actions against endothelial dysfunctions associated with oxidative stress as in chronic 
diseases such as hypertension and diabetes mellitus.  
 
Despite mixed outcomes from clinical trials of vitamin E and C, the good safety profile 
of boldine and its potent antioxidant action, should provided new impetus to conduct 
preliminary investigations of the effectiveness of the alkaloid either for treatment or as 
prophylaxis, in hypertensive and diabetic patients.  Combining boldine with current 
treatments for hypertension and diabetes mellitus would be another area of study given 
that drug combinations have been shown to be successful for the treatment of 
hypertension.   Finally, other potential studies with boldine should examine the effects 
of longer treatment durations, and other mechanisms including anti-inflammatory 
and  the central actions of the aporphine alkaloid. 
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Appendix A: Effect of 0.1 % DMSO (vehicle) and MPG extracts on ACh endothelium-
dependent relaxation. (A) 0.1 % DMSO did not alter the ACh responses in the presence 
of NADH (300 µM) (B) 0.5 μg/ml, 5 μg/ml and 50 μg/ml Phoebe grandis (stem bark) 
methanolic extract did not affect the  ACh relaxation in rat aortic rings. Results are 
mean ± SEM (n = 5-6). * P < 0.05 compared to control. 
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Appendix B: Effect of chronic boldine treatment on total plasma nitrate/nitrite (NOx) in 
WKY and SHR rats. The reduced total NOx observed in SHR was increased in boldine-
treated SHR rats. Data are expressed as mean ± SEM (n= 6-7).  # P < 0.01 compared to 
WKY, * P < 0.05 compared to SHR. 
 
 
 
 
 
 
                                                                                                                List of Appendices 
120 
 
p67phox
GAPDH
N
G
H
G
H
G
 +
 B
H
G
 +
 T
0.0
0.5
1.0
1.5
p
6
7
p
h
o
x /
G
A
P
D
H
(C
o
m
p
a
re
d
 t
o
 N
G
 c
o
n
tr
o
l)
N
G
H
G
H
G
 +
 B
H
G
 +
 T
0.0
0.5
1.0
1.5
R
a
c
1
/G
A
P
D
H
(C
o
m
p
a
re
d
 t
o
 N
G
 c
o
n
tr
o
l)
Rac1
GAPDH
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix C: The protein expression of p67
phox
 (A) and Rac1 (B) was not changed by 
co-treatment of boldine or tempol. Results are mean ± SEM of 3 experiments using 
RAECs from different rats. NG: normal glucose (5 mM glucose + 25 mM mannitol as 
osmotic control).   
A 
B 
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Appendix D: SNP-induced endothelium-independent relaxations were not altered by 
boldine treatment. Results are shown as mean ± SEM (n=6).   
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Appendix E: The protein expression of glutathione (GSH) antioxidant was not affected 
by treatment of boldine or tempol in rat aortic endothelial cells (RAECs) exposed to 
high glucose for 48 h of Results are mean ± SEM of 3 experiments using RAECs from 
different rats. NG: normal glucose (5 mM glucose + 25 mM mannitol as osmotic 
control).   
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Appendix F: The protein expression of eNOS was not affected by treatment of boldine 
or tempol in rat aortic endothelial cells (RAECs) exposed to high glucose for 48 h of 
Results are mean ± SEM of 3 experiments using RAECs from different rats. NG: 
normal glucose (5 mM glucose + 25 mM mannitol as osmotic control).   
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Appendix G: The graph showing the ratio of phenylephrine (Phe, 1 μM)-induced 
contraction before and after the incubation of boldine (1 μM) or prazocin (0.3 nM) for 
30 min from isolated aorta of SD rat. Prazocin significantly reduced the ratio (second 
Phe contraction over the first Phe contraction) compared to boldine. 
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Appendix H: Pre- and post-treatment plasma glucose level among different groups of 
mice 
Group Plasma glucose (mmol/l) 
Before After 
Vehicle  29.83 ± 0.60 26.80 ± 2.28 
Boldine  29.30 ± 0.76 27.64 ± 1.86 
Tempol 29.31 ± 1.13 27.58 ± 1.62 
 
db/db mice were given with boldine (20mg/kg/daily, i.p.).  Results are mean±SEM of 6 
separate experiments.   
 
Appendix I: Lipid profile in db/db chronic treated with vehicle, boldine or tempol. 
  Vehicle Boldine Tempol 
Total cholesterol (mg/dl) 70.33 ± 5.90 84.11 ± 20.01 74.91 ± 6.74 
Triglyceride (mg/dl) 71.15 ± 11.63 82.56 ± 0.07 118.20 ± 20.80 
HDL (mg/dl) 47.24 ± 2.26 45.81 ± 9.03 44.44 ± 1.85 
non-HDL (mg/dl) 23.09 ± 6.30 38.30 ± 12.99 30.46 ± 6.55 
 
Effect of chronic boldine treatment (20mg/kg/daily, i.p.) on levels of total cholesterol, 
triglyceride, HDL and non-HDL in vehicle- or boldine-treated db/db mice. Results are 
mean ± SEM of 6 separate experiments.  
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Appendix J: Pre-treatment with boldine or tempol reduced ROS production that was 
elevated in high glucose (HG)-treated MAECs NG: normal glucose (5 mM glucose and 
25 mM mannitol as osmotic control of HG). Results are means ± SEM of 4-6 separate 
experiments. # P <0.05 compared with NG; * P < 0.05 compared with HG. 
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